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Rapid advances in reproductive technologies have led to unprecedented shifts 
in debates about regulation of, and access to, these services.  In a world where a single 
cycle of in vitro fertilization (IVF) costs upwards of $10,000, questions arise about 
whether and, if so, why public money should fund IVF.  To examine the politics at the 
core of this complex ethical and practical dilemma, this thesis explores the political 
decision-making processes underlying two notable pieces of IVF funding legislation: 
Ontario’s 1993 decision to remove IVF from its government-provided health 
insurance and Quebec’s 2008 decision to fund three rounds of IVF for all citizens.  
Through these case studies, this thesis examines the patterns of interaction between 
non-governmental stakeholders in IVF funding decision-making forums and seeks to 
determine which mechanisms these stakeholders employ to shape medical funding 
decisions more broadly.  Further, it explores the relationship between professional and 
lay expertise in political forums.  Testing the assertions of past research, this study 
seeks to ascertain whether lay experts have gained substantial political credibility in 
these Canadian provinces.  To answer these questions, I completed a textual analysis 
of 37 parliamentary debate records and 65 newspaper articles spanning two provinces 
and twelve years.  I coded the records for each stakeholder’s framing of their stance on 
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IVF issues and for the relative standing of different categories of stakeholders in both 
the media and political arenas.  These results revealed medical professionals’ and 
professional organizations’ continued dominance in IVF funding decisions, 
particularly in Ontario.  In Quebec, key lay experts, such as infertility advocacy 
organizations and public figures, moderated this dominance.  Comparison of 
stakeholder standing and framing in these two cases further suggests that the greater 
heterogeneity of stakeholders represented in decision-making forums in Quebec was 
an important factor in promoting Quebec’s decision to fund the service.  Indeed, while 
many of the same frames were deployed in the two provinces, lay experts in Quebec 
reinforced frames presented by professional witnesses and likely played a role in 
Quebec’s pro-funding decision. Ultimately, professionals still firmly control medical 
funding decision-making processes in Canada, though lay experts of various kinds are 
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“The first step in de-insuring services should be to define ‘medically 
necessary’…Initially, the process should be a joint one with the 
[Ontario Medical Association] and [Ministry of Health].  Input should 
then be sought from expert groups, for example, [the Infertility 
Awareness Association of Canada], as the representative of the infertile 
population.  Then the public should be allowed to participate in this 
very important discussion.”  
 
– Infertility Awareness Association of Canada (November 1, 
1993, Standing Committee on Social Development, Ontario) 
 
 
Improvements in infertility treatments and reproductive technologies have 
created numerous means by which individuals struggling with infertility may become 
pregnant.  From intrauterine insemination to in vitro fertilization (IVF), reproductive 
technologies help to improve the chances that individuals can have the child they 
want—if they can afford it.  These new technologies come at a massive cost ($10,000 
or more per cycle) that may be prohibitive to a large proportion of the population 
(Bouzayen & Eggertson 2009:243).   In Canada, where health insurance is publicly 
funded, the expense raises the question of whether—and, if so, why—government 
health insurance should pay for procedures such as IVF.   At its heart, the issue of IVF 
funding calls into question who has a right to have children and at what cost.  This 
analysis addresses the only two Canadian provinces—indeed, the only states or 
provinces in North America—with publicly-funded IVF.  Through comparison of the 
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decision-making process underlying Ontario’s 1993 resolution restricting IVF funding 
to individuals with bilateral blocked fallopian tubes and the process that determined 
Quebec’s 2008 decision to fund IVF for all, I locate social and political factors 
motivating a province’s decision to publicly fund in vitro fertilization.   
In 1993, the Ontarian Parliament introduced the highly disputed Expenditure 
Control Plan Statute Law Amendment Act (Bill 50, December 14, 1993).  This act 
amended the existing Health Insurance Act and Hospital Labour Disputes Arbitration 
Act and, in doing so, restructured government-health provider relations, revised health 
system administration, and delisted a number of health services—including in vitro 
fertilization except for women with bilateral blocked fallopian tubes—from funding 
under Ontario’s state-provided Ontario Health Insurance Plan (OHIP).  Fifteen years 
later, in 2008, amidst conversations about regulating new reproductive technologies, 
Quebec’s Parliament made the lauded and controversial decision to include in vitro 
fertilization in Quebec’s government-provided health insurance plan.  Having 
previously offered a tax credit reimbursing 30% of an IVF cycle’s cost, the 
government opted to expand coverage to fund three full rounds of in vitro fertilization 
for all individuals.  While it is important to acknowledge that fifteen years and a 
number of national legislations—including Canada’s Assisted Human Reproduction 
Act (2006)
1—passed between Ontario’s decision to defund IVF and Quebec’s decision 
to expand its coverage, comparison of these two cases presents fascinating insight into 
the political processes underlying medical funding decisions and the interplay between 
                                                 
1
 In 2006, the Canadian government issued Assisted Human Reproduction to regulate the use and 
research of reproductive technologies.  This act outlaws human cloning, enacts measures to protect the 
safety of individuals undergoing treatments, and requires that research related to infertility treatments 
take place in regulated environments (Health Canada 2008). 
3 
 
stakeholders in Canadian legislative forums.  This thesis specifically examines the 
roles of the public and of professional and lay experts in parliamentary hearings and in 
the mass media in both provinces.  The rest of this chapter will introduce expert 
research on these topics, describe the study design, and outline the plan of thesis. 
PUBLIC VOICES IN THE POLITICAL SPHERE 
 Political science theory and research traditionally suggests that public opinion 
is an essential component of legislative processes and that politicians act primarily in 
hopes of gaining public favor to secure votes for reelection (Brettschneider 1996; 
Burstein 2003, 2006; Pettinicchio 2010; Stimson, MacKuen, and Erikson 1995).  
Numerous researchers have noted, however, that many cases contradict the assumed 
tight correlation between the public’s desires and politicians’ actions (Petry and 
Mendelsohn 2004).  As political scientists Francois Petry and Matthew Mendelsohn 
(2004:505) contend, “there is a firmly embedded assumption in the popular folklore of 
politics that politicians are highly attentive to public opinion.”  This myth is 
particularly false in the case of medical funding debates, where politicians and 
professionals often reign heavily dominant (Contandriopoulos 2004; Freidson 1986; 
Jasanoff 1990).  Meanwhile, variation in government structure—federalism versus 
parliamentary systems, for example—may alter the correlation between public opinion 
and policy outcomes (Brettschneider 1996).  In Canada’s parliamentary system, in 
particular, the party system isolates policymakers from public opinion and creates an 
environment antagonistic to active citizen involvement (Mendelsohn 1996; Petry and 
Mendelsohn 2004; Pettinicchio 2010).  Further, as L. Graham Smith (1982, 1984) 
contends, public participation in Canada has primarily been restricted to operational 
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planning—such as intervention design and implementation—and has not extended to 
normative debates about the ideals underlying policy decisions.  Following from this, 
it is likely that public opinion may have little influence on problem definition in 
Canada’s medical funding debates.   
PROFESSIONAL AND LAY EXPERTISE 
 An alternative approach to understanding the public’s importance in political 
decision-making emphasizes the roles of social movements and organized advocates.  
Social movement analysts agree that non-experts face challenges in gaining access to 
political forums, but recent developments in the field suggest a rising tension between 
professional and lay experts in the political realm and an increasing relevance of non-
professional opinion, particularly in medical and environmental debates (Epstein 
1996; Eyal and Buchholz 2010; Newman et al. 2004).   As Newman et al. (2004:220) 
articulate, “service users” may be “conceptualized very differently from the 
‘clamorous public’ or ‘demanding consumers’” that past research suggests.  Indeed, 
these patients or consumers may be “‘experts’ whose knowledge and experience can 
contribute to the development of new policies and practices” (Newman et al. 
2004:221).  This thesis examines lay experts’ emergence and assesses the relative 
influence of the public, professionals, and lay experts in shaping IVF funding 
decisions.  In doing so, it seeks to uncover the factors impacting non-governmental 





Traditions of Professionalism 
 Andrew Abbott (1988:1) begins The System of Professions with the simple, yet 
powerful, statement that “the professions dominate our world.”  And, indeed, medical 
professionals and professional organizations have traditionally heavily dominated the 
medical policy field.  Advice from scientific experts regulates outcomes and often 
serves as the authoritative voice on topics ranging from pharmaceutical regulations to 
environmental reforms (Davis and Abraham 2010; Jasanoff 1990).  As Sheila Jasanoff 
(1990:250) argues, in legislative processes, scientific advice is “part of a necessary 
process of political accommodation among science, society, and the state.”  Further, “a 
state of knowledge that satisfies tests of scientific acceptability and supports reasoned 
decision-making” is essential in constructing an effective political process (Jasanoff 
1990:250).  While professionals are far from the only players in legislative forums 
and, arguably, are not necessarily “the prime movers of those processes,” they hold a 
uniquely defined position among non-governmental stakeholders (Freidson 1986:205).  
Legislative processes rely heavily on the positioning of actors within a hierarchical 
system and the system therefore expects these actors to complete unique duties and 
present different perspectives (Freidson 1986:230).  In essence, as Abbott (1988) aptly 
contends, professionalism exists because “our market-based occupational structure 
favors employment based on personally held resources, whether of knowledge or of 
wealth” (Abbott 1988:234).  In the case of medical funding decisions, medical 
professionals maintain their dominance because they have unique control over 
healthcare provision and a unique understanding of medical conditions and treatments. 
6 
 
 Despite this traditional dominance, recent work in the sociology of expertise 
suggests a decline in reliance on professional expertise.  Eliot Freidson (1986:230) 
contends that words like “technique, social control, hegemony, domination or 
monopoly of discourse” are too strong to describe the role of professionals in political 
economy.  Similarly, Abbott (1988:325) maintains that the other forces that play 
alongside professionalism “may have finally become stronger” while Gil Eyal and 
Larissa Buchholz (2010) argue that a variety of actors—ranging from consumer 
unions to patient groups—have gained traction and the capacity to effect change in 
politics.  In sum, though professionals maintain a strong legacy of dominance and 
ownership of scientific and medical knowledge, more recent research suggests that 
trends are shifting and other stakeholders are gaining respect and influence. 
The Rise of Lay Expertise 
 While professionals and intellectuals have traditionally controlled medical 
decisions and health-related legislation, lay expertise appears to be rising in 
predominance and there is a growing belief among sociologists in the value of non-
professional stakeholder involvement in scientific fields (Epstein 1996; Eyal and 
Buchholz 2010; Wynne 1996; Zola 1972).  While sociologists do not advocate for the 
complete exclusion of medical professionals from decision-making, many argue along 
the lines of Irving Kenneth Zola’s (1972:503) point that “patients have so much to 
teach their doctors as do students their professors and children their parents.”  In fact, 
lay people may be better equipped to represent the social dimensions of scientific 
knowledge and to identify the cultural and social implications of a given set of reforms 
(Wynne 1996).  For example, in Brian Wynne’s (1996:40) examination of English 
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sheep farmers’ reactions to radioactive consequences of the 1986 Chernobyl accident, 
he notes that “lay people…showed themselves to be more ready than the scientific 
experts to reflect upon the status of their own knowledge” and to “relate it to that of 
others and their own social identities.”  Indeed, literature makes clear that lay experts’ 
involvement in political decision-making complements and reinforces professional 
experts’ advice.   
Further research highlights the great strides that have resulted from the actions 
of patient groups and of other non-professional actors. Steven Epstein (1996) provides 
a particularly strong analysis of lay experts’ role in the HIV/AIDS movement in the 
United States as he argues that the success of the AIDS movement demonstrates that 
social movements’ engagement with science can expand and fortify the movements 
and their aims.  Importantly, Epstein (1996:419) contends that activists in the AIDS 
movement constructed themselves as an “obligatory passage point” and, in so doing, 
established their roles as representatives of the people.  Ultimately, Epstein and others 
suggest that, by learning the language of medical experts, activists—ranging from 
health educators, to journalists, to HIV positive individuals—can establish credibility 
within the professional domain and therefore gain access to political forums and 
influence in legislative decisions. 
 Though these examples hint at the increasing presence of laypeople in political 
forums, there is certainly no consensus about the relevance of lay expertise in defining 
medical policy decisions.  Some argue that “unmediated anecdotal evidence” may 
corrupt medical decisions and have negative implications for safety and public health 
(Davis and Abraham 2010).  Meanwhile,  Lindsay Prior (2003:53) goes so far as to 
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argue that laymen are not experts by citing the dictionary definitions of “layman” and 
“expert”: 
‘Layman’: 1. One of the laity. 2. An outsider or non-expert (esp. in 
relation to law or medicine) 
‘Expert’: 2. Experienced (in), having experience (of). 2. Trained 
by practice, skilled. 
 
Lay knowledge, Prior maintains, is not as valuable as professional knowledge and 
cannot be considered as such.  While she acknowledges the value in assessing how 
affected individuals think and feel about their circumstances, Prior (2003:41) argues 
that there exists “a line of boundary around the domain of expertise.”  As she 
concludes: “to paraphrase the sentiments of Max Weber (1948), scientific and medical 
experts might not be able to instruct us about what we ought to do, but they can 
instruct us about what is and is not possible to do—and how, exactly, to do it” (Prior 
2003:54).  Science and medicine, these pro-expertise advocates contend, are very 
much still relevant, critical, and dominant in the political realm.   
 Overall, though some academics question laypeople’s relevance in policy 
debates, the predominant view is that lay expertise is increasingly pertinent in today’s 
government.  Indeed, as Epstein (1995:408) concludes, “the arena of fact making 
encompasses not just immunologists, virologists, molecular biologists, 
epidemiologists, physicians, and federal health authorities—but various credentialed 
experts plus the mass media and the pharmaceutical and biotechnology companies.”  
Further, activists have been increasingly involved in movements ranging from AIDS 
activism to drug regulation and have fought to protect values “other than the pursuit of 
science” as they “[transform] the practices by which science constitutes knowledge” 
(Epstein 1995:427).  While social movements of course continue to struggle against 
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traditions of professionalism, advocates have seen a “new wave of democratization” 
arise in health care debates and past research suggests optimistic outcomes for this 
trend (Epstein 1996:349). 
Interest Groups, SMOs, and Advocacy Organizations.  Lay experts gain 
traction and credibility through mobilization and the formation of social movement 
organizations. Previous sociological works suggest that interest groups can be broadly 
defined as “voluntary associations independent of the political system that attempt to 
influence the government” (Andrews and Edwards 2004:481; Burstein 1998).  
Kenneth Andrews and Bob Edwards (2004:481) specifically cite Jeffrey Berry who 
defines a public interest group specifically as one “that seeks a collective good, the 
achievement of which will not selectively and materially benefit the membership or 
activists of the organization.”  On the other hand, a social movement organization is 
conceptualized as a group that engages with a social movement outside of institutions 
of political decision-making (Andrews and Edwards 2004:482). 
While analyses frequently distinguish between social movements and interest 
groups, current research argues that the line between these types of groups is not as 
clear as previously indicated (Andrews and Edwards 2004; Best 2012; Burstein 1998).  
As Andrews and Edwards (2004:485) highlight, “many of the influential definitions of 
public interest groups, social movement organizations, and nonprofit advocacy 
organizations share a common focus on the pursuit of good framed in the public 
interest.”2   
                                                 
2For the purposes of this thesis, I define “interest groups” as voluntary associations pursuing specific 
benefits in their constituents’ interests (Andrews and Edwards 2004; Best 2012).  I use the more 
specific term “advocacy organization” to represent non-professional interest groups.   
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In the realm of medical funding legislation, interest groups present joint 
challenges “to medical policy, public health policy and politics, belief systems, 
research and practice” and incorporate supporters ranging from informal organizations 
to media networks (Brown and Zavestoski 2004:679).  These organizations have far-
reaching aims and effects including the resolution of health access issues, reduction of 
the traumas of disease experiences, and reduction of racial, gender-based, or other 
health inequalities (Brown and Zavestoski 2004:679).  These health social 
organizations build upon related movements, target increased public awareness of 
health access issues, and  mobilize around social issues in healthcare to improve the 
experiences of “ill” populations (Brown et al. 2004).  
Interest groups stand at the intersection of the state and the public.  In claiming 
to represent the good of the people, these organizations work hand-in-hand with 
policymakers to secure their beneficiaries’ best interests and, in doing so, can alter the 
landscape of medical research, service provision, and the social and political structures 
of society more broadly. 
METHODS OF INTERVENTION 
 Lay experts employ a number of mechanisms to intervene in political 
processes.  First, stakeholders influence mass media and public opinion to alter the 
agenda-setting process and move issues up or down policymakers’ task lists (Andrews 
and Edwards 2004).  Further, organizations seek access to decision-making forums, 
push to achieve policies that are favorable for their constituents, “monitor and shap[e] 
implementation,” and influence the long-term priorities and resource allocation of 
governments and other political machines (Andrews and Edwards 2004:479; Evans 
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1996).  Specifically, advocacy organizations participate in decision-making forums to 
“broaden the focus” of issues or “[divert attention] to aspects of the issue over which 
[they] have greater control” (Pettinicchio 2010:132).  Through direct participation in 
the political process, actors also assert their legitimacy and directly target undecided 
policymakers and those who previously opposed their initiatives (Andrews and 
Edwards 2004; R. A. Smith 1984).  By providing fresh insight relating directly to their 
policy issue of interest, advocacy organizations may push for reforms of related 
policies and reinforce existing messages relating to their cause (Burstein and Linton 
2002).  David Pettinicchio (2010:132) cites a Bauer, Pool, and Dexter (1963), which 
demonstrates through interviews that “members of Congress will hear anyone who 
brings fresh information on an issue.”  Specifically, research suggests that advocates 
are most effective when they provide elected officials with the resources and 
information needed to successfully win reelection (Burstein and Linton 2002).  
Additionally, interest groups monitor subsequent endeavors of policymakers to 
enforce sustained support and ensure that the benefits of their efforts continue past the 
initial mandates set by policymakers (Andrews and Edwards 2004).  Finally, as the 
Mississippi Civil Rights Movement of the 1950s and 1960s demonstrates, advocates 
interrupt program functions, negotiate with officials, and stage protests (Andrews 
2001:89; King, Bentele, and Soule 2007). 
 A successful advocacy initiative is predicated on a combination of the 
previously discussed actions, favorable group characteristics, and a constructive 
political context.  In his assessment of the factors fostering the American Medical 
Association’s (AMA) rise to power, Mark Peterson (2001) highlights key 
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characteristics of powerful interest groups in politics.  The rise of the AMA indicates 
that traits such as information control and recognition as a “knowledge-based, high-
status” group lend themselves to political power (Peterson 2001:1150).  Further, 
frequent contact with policymakers and possession of a specific political “niche” 
increases an organization’s credibility and prominence in a given area (Peterson 
2001:1150). Meanwhile, a “large and dispersed membership” ensures that the 
organization has a large reach and expansive potential influence (Amenta et al. 2010; 
Peterson 2001:1150).  Finally, organizational resources, knowledge of the target 
population, and funding availability ease the challenges of disseminating specialized 
information to the population and to policymakers (Amenta et al. 2010; Peterson 
2001:1150).   
These organizational characteristics must be coupled with a productive 
political context to ensure advocacy organizations’ success.  Amenta, et al. (2010) 
contend that the most successful movements deal with issues that are already on the 
legislative agenda.  Successful social movements are also fought based on “credible” 
and “plausible” claims directed both at the elite and at society as a whole (Amenta et 
al. 2010:299; Epstein 1996).  As these authors aptly state “SMOs [social movement 
organizations] almost invariably claim to represent a group extending beyond the 
organization’s adherents and make demands that would provide collective benefits to 
that larger group” (Amenta et al. 2010:290).  In short, the keys to a successful 
advocacy effort are the mobilization of a diverse set of leaders and access to a range of 
resources from members and the general public alike (Amenta et al. 2010). 
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Policy change occurs through the processes of “problem recognition and 
agenda setting; the specification of policy options; and the politics of selecting among 
proposals and enacting legislation” (Burstein 1991:346).  Throughout these processes, 
policy, culture and social movements interact and shape relationships, providing a 
framework for the activities of both advocates and political actors (Best 2012; 
Burstein 1991; Cress and D. A. Snow 2000).   
Shaping Discourse in the Media 
 This thesis focuses both on the direct participation of stakeholders in decision-
making forums and on the impact of agenda-setting through the mass media. While 
public discourse is presented in forums ranging from parliament to scientific 
congresses to conversations between civilians on the street, mass media is the forum in 
which discourse from all of these different arenas interacts and ideas combine (Ferree 
et al. 2002:10–11).  Media is also the forum in which expert knowledge is 
disseminated and, through investigative journalism, on occasion produces  knowledge 
of its own (Blocher 2012).  Media therefore becomes a primary site of political 
contest, develops a significant influence over the other forums of conversation, and 
provides stakeholders a measure for assessing the success of their initiatives (Ferree et 
al. 2002:10).  In turn, the spread of a stakeholder’s frame through mass media may 
lead to a “ripple effect” throughout the various political decision-making arenas 
(Ferree et al. 2002:11).  Therefore, those who are most successful in commandeering 




In general, stakeholders shape cultural definitions and frame issues according 
to their interests to influence both the media and political arenas.  Framing is the 
process by which actors organize “a diverse array of symbols, images, and arguments” 
to construct a coherent picture and argument and shape the meaning and interpretation 
of problems to best suit their beneficiaries’ interests (Ferree et al. 2002:14).  By tying 
these symbols and arguments to an underlying concept which highlights the causes, 
consequences, and potential repercussions of the issue, stakeholders confer specific 
meanings and interpretations to events which may benefit their causes (Ferree et al. 
2002:14).  To achieve direct benefits for their constituents, these stakeholders, in turn, 
construct the variety of political positions that surround contentious issues such as IVF 
funding or access to abortion and may inject their frames into policy debates through 
forums such as the mass media to alter policymakers’ goals and priorities (Benford 
and D. Snow 2000; Cress and D. Snow 2000). 
 To shape policy, public and media discourse constrain policymakers and 
pushes them to conform with “dominant tendencies” to ensure their future reelection 
(Ferree et al. 2002:15).  Indeed, the media is essential to democracy because it enables 
problem solving and deliberation in the interest of the common good (E. Baker 1998; 
Rosen 1996).  As McCombs and Shaw (1972; cited in Pettinicchio 2010) argue, media 
is one of the only ways in which the public—which is not involved in daily political 
exercises—is informed of political events.  While public discourse is only one factor 
amidst many shaping decision-making priorities, “doing badly in mass media 
discourse creates vulnerability in pursuing policy interests” and the ability of 
stakeholders to construct their meanings and interpretations as the most important ones 
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is often central to policy success (Ferree et al. 2002:16).   In short, as Rachel Best 
(2012:796) asserts, it is critical to understand that “culture is not an isolated realm of 
social life that can be separated from politics” and that one of the most fundamental 
tools of health advocates and politicians is the act of cultural redefinition through 
manipulation of the public forum.    
OUTCOMES OF STAKEHOLDER INVOLVEMENT IN POLITICS 
There are three categories of policy outcomes that result from political 
challengers’ interventions and framing efforts.  First, advocacy efforts may impart 
direct benefits—gains for an organization’s specific constituents (Best 2012).  These 
include such impacts as moving items up the policy agenda and altering the content of 
policies to secure benefits for individuals suffering from a particular disease (Best 
2012).  Further, interest group activity may lead to resource redistribution to benefit 
constituents who are more likely to mobilize and advocate on their own behalves 
(Berry 1999; Best 2012; Radcliff and Saiz 1998).  For example, if infertile couples 
organize themselves in support of their cause, the reallocation of resources may 
advance their efforts and reduce the social and political power of the majority or elite 
classes (Best 2012).  Finally, advocacy may lead to systemic effects altering the 
overall structures of policy procedures and government activities (Best 2012).  As Best 
(2012:782; see also Armstrong and M. Bernstein 2008) asserts, systematic changes 
alter “the rules of the game for all participants.”  In medical research funding in the 
United States, “disease advocacy reshaped funding distributions, changed the 
perceived beneficiaries of policies, promoted metrics for commensuration, and made 
cultural categories of worth increasingly relevant to policymaking” (Best 2012:780).  
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Of particular note, Best (2012:784) argues that disease advocacy led Congress to view 
disease patients, rather than the general public, as the main medical research funding 
beneficiaries.  When patients are viewed as beneficiaries, moral and ethical 
considerations of worthiness contribute to funding decisions and those patients’ 
interests may be weighed against the general public’s interests (Best 2012; Steensland 
2006). 
 These discussions of beneficiaries and of adjustments to overall health funding 
priorities are central to the debates explored in this analysis.  As Maureen Baker 
(2008:78) suggests, “not all governments see access to reproductive services or 
declining fertility as problematic.”  The marks of a successful advocacy initiative are 
changed political agendas, altered legislative proposal content, an increase in relevant 
representatives’ votes, and faster passage of legislation (Amenta et al. 2010:301).  This 
thesis therefore considers whether lay experts’ involvement and reframing of funding 
issues led to a significant shift in one of these factors, which subsequently led the 
Ontarian and Quebecois governments to readjust their views on the importance of IVF 
as a state funding priority (M. Baker 2008:78). 
INFERTILITY AND LAY EXPERTISE: AN INTERSECTION 
  Steven Epstein (1996:331) asserts that “without the sustained, interactive 
participation of scientists, the mass media, and voices within the AIDS movement, the 
controversy simply would not have achieved significance, either socially or 
scientifically, and the ‘black box’ (‘HIV causes AIDS’) would never have been 
reopened for consideration.”  This thesis tests Epstein’s ideas in a new realm of 
science within a distinctly different national context.  By assessing different 
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stakeholders’ roles in framing IVF funding discourse in the mass media and in 
political spheres in Ontario and in Quebec, this study examines the patterns of 
interaction between professional and lay experts in infertility debates and attempts to 
determine whether this interplay between stakeholders played a role in problem 
definition and in establishing the two provinces’ divergent funding decisions. 
 Ultimately, I pursue Epstein’s (1995:430) suggestion that an “extended study 
of the relation between biomedicine and social movements could provide for a deeper 
and more comprehensive analysis of the construction of medical knowledge and the 
transformation of medical practice.”  By examining various stakeholders’ standing in 
policy debates and analyzing their framing of the issue, I apply Epstein’s ideas to a 
different medical issue in order to unravel the social dimensions of IVF debates, 
examine how interactions between non-governmental stakeholders shape policy and 
framing in IVF funding debates, and explain the impact of lay expertise on this 
specific case of medical funding decision-making processes. 
METHODOLOGY: SOURCES, CODING, AND STUDY DESIGN 
To examine the interaction between professional and lay expertise in IVF 
funding debates, 37 parliamentary records and 65 newspaper articles spanning two 
provinces and twelve years were analyzed.  The data I collected allows me to answer 
the question “how does the relative presence of different stakeholders in media and 
parliamentary discussions influence problem definition and policy outcomes in IVF 
funding debates?”  This data allows me to demonstrate a correlation between the level 
of involvement of different categories of stakeholders and the framing of IVF debates.  
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It also enables analysis of lay experts’ impacts in shaping Canadian medical funding 
decisions. 
The central concepts in this research are stakeholder credibility, in vitro 
fertilization funding debate framing, and problem definition and agenda setting by 
policymakers.  Credibility was assessed based upon standing—“having a voice” in a 
forum of legislative discussion (Ferree et al. 2002:86).  As Mark Ferree et al. 
(2002:86) articulate, standing is a critical measure of power and influence because 
parliamentary witnesses and media sources are selected “because they speak as or for 
serious players in any given policy domain: individuals or groups who have enough 
political power to make a potential difference in what happens” (Ferree et al. 
2002:86).  Consequently, credibility and the legitimacy of expertise are measured in 
this study based on the frequency of appearances by different categories of 
stakeholders in provincial and national news media and parliamentary sessions in both 
provinces.  Framing and problem definition were coded into a number of categories 
based on previous research on IVF funding, as described in the attached Appendix.  
Methods of Data Collection 
 All data was collected through textual analysis of parliamentary debate records 
and newspaper articles.  Documents published beginning five years before and ending 
two years after each policy decision were examined.  For Ontario, I examined 
documents and media beginning in 1989 and extending until 1995.  For Quebec, I 
studied documents ranging from 2005 to 2011.  I selected the beginning of this range 
based on the date of the very first reference to the discussed policy in legislative 
records.  I elected to code data from after the passage of the bills to ensure that I 
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garnered information about implementation and public and editorial reactions to the 
policies.  I specifically selected the two year timeframe based on initial readings of 
Quebec’s parliamentary testimony which suggested that the major political discussions 
about implementation occurred in the first two years following ratification. 
Parliamentary Debates and Committee Hearings.  To assess standing and 
framing in the political arena, I coded transcripts from meetings of Ontario’s 
Legislative Assembly, Quebec’s National Assembly, and a number of parliamentary 
committees in both provinces.  For Ontario, I specifically coded 8 transcripts from 
Ontario’s Legislative Assembly and 8 transcripts from the Standing Committee on 
Social Development.   For Quebec, I analyzed 11 records from the National Assembly, 
7 from the Committee on Social Affairs, 1 from the Committee on Health and Social 
Services, 1 from the Committee on Citizen Relations, and 1 from the Committee on 
Public Finance.  All of Quebec’s parliamentary transcripts were initially recorded in 
French.  The Columbia Tutoring and Translating Agency translated them to English 
for my purposes.  For both provinces, I coded every document an archive search 
returned.  I used the search terms “in vitro” and “IVF,” as well as the French terms 
“FIV and “fécondation artificielle.”  I also used “Bill 50” and “Expenditure Control 
Plan Statute Law Amendment Act” as search terms for Ontario and “Bill 26,” “Bill 
23,” and “Bill 89” as search terms for Quebec.   
Mass Media.  To ascertain stakeholder presence and impact in the public arena, 
I analyzed articles from three major Canadian newspapers.  To garner a consistent 
national perspective, I coded 7 articles discussing Ontario’s IVF funding debate and 
15 articles regarding Quebec’s from the Toronto-based Globe and Mail—Canada’s 
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centrist “newspaper of record” with a 2011 weekly circulation of 1,906,336 
newspapers (Newspapers Canada 2012).  I also coded articles from one provincial 
newspaper in each province to achieve a more local perspective.  For Ontario, I coded 
18 articles from the liberal, Toronto-based Toronto Star, which had a weekly 
readership of 1,932,385 in 2011 (Newspapers Canada 2012).  Similarly, I coded 25 
articles from the centrist Montreal Gazette—Montreal’s premier English newspaper 
with a 2011 weekly circulation of 806,122 (Newspapers Canada 2012).  In all cases, I 
coded every document my archive search uncovered.  I used the search terms “in 
vitro” and “IVF” to search for relevant articles.  I also searched for “Bill 50” and 
“Expenditure Control Plan Statute Law Amendment Act” in searches relating to 
Ontario and “Bill 26,” “Bill 23,” and “Bill 89” in searches for articles discussing 
Quebec.   
Methods of Data Analysis 
 I first performed a quantitative analysis enumerating the different types of 
media and parliamentary witnesses who appear in hearings and newspaper records 
related to IVF funding.  I then assessed the difference in ratios between Ontario and 
Quebec to establish a baseline understanding of each type of stakeholders’ overall 
presence in the two decision-making processes.  I also enumerated the prevalence of a 
variety of frames and cross-tabulated their use by different types of stakeholders.  The 
low number of available parliamentary and media records relevant to this thesis topic 
limited further quantitative measures.  To reinforce my findings, I complemented this 




Strengths and Limitations 
 Through a combination of qualitative and systematic quantitative analysis, this 
study provides robust and multi-faceted insights into the Canadian political decision-
making process.  Specifically, consideration of the objective numerical presence of 
categories of witnesses coupled with qualitative deconstruction of witnesses’ 
testimony and decision-makers’ discourse provides detailed insight into the factors 
underlying Ontario’s and Quebec’s policy outcomes.  Further, the comparison 
between Ontario and Quebec strengthens the study’s conclusions because the 
provinces demonstrate vastly different outcomes despite existing under the same 
national context.  
 While this study is strong overall, it has a number of limitations.  First, as 
previously mentioned, Quebec’s parliamentary transcripts are recorded primarily in 
French.  As I am unable to read French, I made initial readings of French documents 
using online translation tools and then had the Columbia University Tutoring and 
Translating Agency translate critical sections.  While this service employs experienced 
translators, the involvement of a third party translator must be considered when 
assessing coding accuracy. 
 This thesis faces additional barriers in the representativeness of the research 
design.  Much political decision-making occurs behind closed doors and many 
influences cannot easily be understood via public records analyses (Ferree et al. 2002).  
Public discourse and the information that the government releases are certainly 
important components of the decision-making process, but it is important to be aware 
that there are other factors and conversations that are virtually impossible to gain 
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access to.  Similarly, it is important to consider that the results of this study only really 
apply directly to their specific provincial contexts and that the limited number of 
records available for analysis constrained the statistical significance and 
generalizability of the study’s findings.  
 In addition, the potential for media bias should be considered when assessing 
media analysis results.  While mass media presents essential insight into the manner in 
which debates are presented in the public sphere, it is prone to bias.  The character of 
the event, the political slant of the newspaper, and the character of the issue itself may 
shape decisions to cover events in public media (Earl et al. 2004; Oliver and Maney 
2000).  Further, individual writers may select quotations and references based on their 
own intentions and political views.  That said, designing a study—such as this one—
which draws from consistent and comparable media sources reduces the effect of bias 
(Barranco and Wisler 1999:320).  Further, consideration of what the news media 
covers provides important insight into what is considered important based on “news-
value factors and cultural imperatives” (Barranco and Wisler 1999:320).  In sum, 
while I took measures to control for bias and while media is perhaps the most 
important component of this analysis, the potential for bias in the media outlets’ 
representations of stakeholder perspectives may temper the results. 
Finally, it is important to consider the impact of time elapsed between 
Ontario’s defunding verdict and Quebec’s funding decision.  National reforms—such 
as Canada’s Assisted Human Reproduction Act (2006)—were enacted in this time 
period and may reflect a change in Canadian society’s general views toward IVF 
between 1993 and 2008.  While the Quebec and Ontario examples provide a valuable 
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comparison of different takes on public funding within the same national context, the 
reader must be aware that the Canadian national context and perspective may have 
evolved in the fifteen years between the two pieces of legislation. 
PLAN OF THESIS 
 Chapter 2 examines global trends in IVF funding policies and outlines the 
evolution of Canada’s policies regulating new reproductive technologies.  The chapter 
further discusses how Ontario’s and Quebec’s funding decisions were born of 
Canada’s national policies and explains the legislative processes in both provinces.  
 Chapter 3 outlines the role of various stakeholders in shaping problem 
definition and agenda setting in Ontarian and Quebecois parliaments.  Through 
analysis of transcripts from parliamentary assembly and committee hearings, this 
chapter argues that medical professionals and interest groups maintain dominant roles 
in both provinces’ political arenas.  Further, this chapter assesses dominant frames in 
IVF funding debates and contends that conflict over medical necessity definition is 
central to IVF funding decision-making process.  The chapter suggests that the 
diversity of stakeholders represented in Quebec’s political arena enabled its positive 
funding outcome. 
 Chapter 4 establishes the media’s role in shaping decision-making processes 
and assesses trends in stakeholder standing and framing in news media coverage of 
IVF funding debates.  The chapter highlights the greater diversity of stakeholders 
represented in the news media and examines the contexts in which statements by 
members of the public are deployed in the public forum.  Analysis of media coverage 
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reinforces the ideas presented in Chapter 3 and the assertion that diverse stakeholders 
reinforce the same frames and ideas from multiple perspectives to gain traction. 
 Chapter 5 draws conclusions from both the parliamentary records discussed in 
Chapter 3 and the media sources outlined in Chapter 4.  This chapter argues that 
professionals maintain their unique position of power in defining and shaping their 
areas of expertise, but that lay expertise may present a similarly influential perspective 
when a diversity of stakeholders come together in support of shared goals.  Indeed, 
Chapter 5 concludes that the difference in outcome for Ontario versus Quebec may be 
explained, at least in part, by the relatively homogenous set of witnesses who 















The two Canadian cases discussed in this thesis inform and are informed by 
parallel debates occurring across the Western World.  From Austria to the United 
States, countries are challenged to define the limits of and access to emerging new 
reproductive technologies.  Philosophies about whether IVF should be publicly funded 
vary, with countries such as Belgium and France providing full public coverage of 
IVF for women under the age of forty, while others, such as the United States, have 
taken a more hands off approach that leaves the decision to private insurance 
companies (Berg Brigham, Cadier, and Chevreul 2013; Neumann 1997).  While public 
funding of IVF is certainly contingent on the existence of public healthcare and 
generally exists in democratic systems, research suggests a series of additional social 
and political factors that impact funding decisions. 
  The value of reproduction and of access to IVF may be understood by 
examining the variety of political, social, and economic rationales that a variety of 
stakeholders have historically utilized to perpetuate their positions on IVF funding 
legislation.  State-funded IVF is most frequently presented in newspaper articles and 
academic literature as a financial decision—intended to decrease the financial burden 
of multiple pregnancies and premature births caused by the overuse of cheaper and 
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riskier forms of fertility treatments (Bouzayen and Eggertson 2009:243).   As Renda 
Bouzayen and Laura Eggerston (2009:243) assert: “For infertile couples, the cost of 
becoming pregnant is largely a private matter in most of Canada…However, the cost 
of treating complications from multiple births that often occur following advanced 
fertility treatments is a public one.” However, some literature questions the cost-
effectiveness of publicly funding IVF and contends that funding the service may 
undermine the improvement of preventative services and therefore lead to negative 
health impacts and economic loss (Smajdor 2007:468).  In a similar vein, some 
opponents argue that maximizing the public good does not mean covering everything, 
as “unlimited needs cannot be covered by a finite budget” (Witt et al. 2002:29). 
  Relevant studies also suggest a number of non-financial rationales presented in 
support of publicly-funded in vitro fertilization.  First, some stakeholders argue that 
IVF should be publicly funded because infertility is a medical condition and IVF is a 
clinically appropriate treatment (Mladovsky and Sorenson 2010).  Along these lines, 
Elizabeth Sternke (2010:xi, 223) asserts that “infertility is a socially constructed 
disability” because inability to fulfill “gender expectations” and their “social 
responsibilities as mothers” compromises women’s psychological well-being.  Anne 
Fidler and Judith Bernstein (1999:495) further argue that “issues related to infertility 
have a significant impact not only on the health and well-being of the individual or 
couple affected but on society as a whole.”  The authors agree that the “psychological 
effects are similar to those of cancer and heart disease…social isolation, clinical 
depression, and reduced job performance and life satisfaction” (Fidler and Bernstein 
1999:497).  Ultimately, it is clear that issues of medical necessity and the desire to 
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prevent the causes and consequences of infertility are central to in vitro fertilization 
funding debates worldwide. 
  Another set of arguments constructs IVF funding as a social imperative.  First, 
some stakeholders contend that access to funded IVF is a human right (Mladovsky and 
Sorenson 2010).  Article 12 of the International Covenant on Economic, Social and 
Cultural Rights (ICESCR) defines the right to health as ‘‘the right of everyone to the 
enjoyment of the highest attainable standard of physical and mental health’’ and 
implores that: 
 …health facilities, goods and services must be affordable for all. 
Payment…has to be based on the principle of equity, ensuring that 
these services, whether privately or publicly provided, are affordable 
for all, including socially disadvantaged groups. Equity demands that 
poorer households should not be disproportionately burdened with 
health expenses as compared to richer households. (Committee on 
Economic, Social and Cultural Rights 2000) 
 
Meanwhile, the UN Declaration of Human Rights states in Article 16 that “Men and 
women of full age, without any limitation due to race, nationality or religion, have the 
right to marry and found a family” (Mladovsky and Sorenson 2010:121–122).  Though 
some would argue “that in a world of many competing needs, not all needs can 
become rights,” others contend that infertile couples “are required to pay into the 
insurance pool that provides pregnancy coverage for others while receiving little or no 
support for their own family-building needs” (Fidler and J. Bernstein 1999:505).  
Similarly, many stakeholders assert that publicly-funded IVF is justified because 
health inequalities are unjust (Mladovsky and Sorenson 2010:121).  In Canada 
specifically, Edward Hughes and Mita Giacomini (2001:438) express concerns that 
“the private funding of IVF creates a potential mal-distribution of resources along two 
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population dimensions: between the sub-fertile and those without fertility concerns 
and between the wealthy and the poor.”  While mandated coverage may not eliminate 
all access issues—due to discrepancies in geographical distribution of fertility centers 
and quality of services—public funding of IVF theoretically gives all individuals 
access to some degree of IVF services (Mladovsky and Sorenson 2010:122).  Finally, 
some stakeholders support public funding of IVF to stimulate the country’s total 
fertility rate, reducing the social burdens of an aging society with a waning birth rate 
(Mladovsky and Sorenson 2010:123).  Together these rationales indicate a social 
obligation and moral imperative for publicly-funded IVF. 
IN VITRO FERTILIZATION POLICY IN CANADA 
Before assessing the application of these debates to Ontarian and Quebecois 
contexts, it is important to consider the legislative processes defining a bill’s trajectory 
in each province.  In Ontario, the first step after a sponsor introduces a bill is its first 
reading, where the purpose of the bill is explained to the Legislative Assembly 
(Legislative Research Service 2011).  A second reading follows, including initial 
debates between Members of Parliament about the principle of the bill (Legislative 
Research Service 2011).  Generally, after the second reading, a legislative committee 
reviews the bill.  At this time, public hearings are conducted, amendments are 
considered, and witness testimony is gathered (Legislative Research Service 2011).  
Finally, the committee reports recommendations to the House and, during a third 
reading, the bill is voted on for final approval (Legislative Research Service 2011).  If 




The legislative process in Quebec is much like the process in Ontario.  After 
the bill sponsors’ introduction, Members of National Assembly (MNAs) assess the 
needs and opinions of people that the bill would affect and the Government House 
Leader refers the bill to a committee for further assessment (Assemblee Nationale 
Quebec 2013).  The MNAs then debate the principle of the bill before a parliamentary 
committee studies it (Assemblee Nationale Quebec 2013).  The committee stage is 
generally the point at which external witnesses are seen.  Finally, the committee 
reports to the Assembly, a vote takes place, and, if the bill is passed, it is moved 
forward for assent by the Lieutenant-Governor (Assemblee Nationale Quebec 2013). 
 Through these multistep processes, regulation and funding of reproductive 
technologies were thoroughly examined and debated at both the national and 
provincial levels.  Via these mechanisms, the progression of policies and debates in 
Canada and its provinces emerged consistent with global discourse and events.  In 
1993, amidst rising concerns about the ethical, social, and legal ramifications of new 
reproductive technologies, the Canadian government initiated the Royal Commission 
on New Reproductive Technologies (Chenier 1994).  The Commission published a 
report detailing safety and ethical guidelines for the use of reproductive technologies 
based on eight principles: “individual autonomy, equality, respect for human life and 
dignity, protection of the vulnerable, non-commercialization of reproduction, 
appropriate use of resources, accountability, and achieving balance between individual 
and collective interests” (Chenier 1994).  The report recommended the restriction of 
some practices—such as the sale of human eggs and sperm—and suggested the 
establishment the National Reproductive Technologies Commission (NRTC) to 
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oversee research and implementation of other services, including sperm collection, 
human zygote research, and assisted conception services (Chenier 1994).  Further, the 
report stated that in vitro fertilization has only proven effective in cases with bilateral 
blocked fallopian tubes (Chenier 1994).  The 1993 Royal Commission on New 
Reproductive Technologies served as an essential building block for the 2006 Assisted 
Human Reproduction Act.  This act of the Canadian federal government regulates 
research on and use of new reproductive technologies (Health Canada 2008).  The act 
outlaws practices such as human cloning, enacts safety measures to protect those 
undergoing infertility treatments, and requires that research related to reproductive 
technologies take place in a regulated environment (Health Canada 2008). Together, 
these national initiatives serve as a clear basis for provincial and national decisions 
regarding the funding of infertility services. 
 The provincial legislations discussed in this thesis—namely Ontario’s 
Expenditure Control Plan Statute Law Amendment Act (Bill 50) and Quebec’s 
ratification of IVF funding—have clear roots in these national policies.  Indeed, it was 
the recommendations of the Commission on New Reproductive Technologies that 
spurred Ontario’s 1993 decision to reexamine its previous policies that included public 
funding of IVF.  Ultimately, Bill 50—which amended the Health Insurance Act and 
Hospital Labour Disputes Arbitration Act—restructured the relationship between the 
government and health providers and delisted a number of services from Ontario’s 
Ontario Health Insurance Plan (OHIP).  In keeping with the recommendations of the 
Royal Commission on New Reproductive Technologies, among these delisted services 
was in vitro fertilization except for women with bilateral blocked fallopian tubes.   
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  Past research suggests four major goals for the defunding of IVF in Ontario: 
(1) to reduce public costs associated with IVF usage, (2) to assert that public funding 
should only be used for “medically necessary” services, (3) to promote evidence-of-
effectiveness-based decisions, and (4) to work toward applying the Royal Commission 
on New Reproductive Technologies recommendations (Giacomini, Hurley, and 
Stoddart 2000).  However, additional research suggests a series of tensions underlying 
these apparently straightforward claims.  First, authors confirm the importance of 
medical necessity as they argue that “‘medical necessity’ was inconsistently defined 
and was used to refer to a number of factors ranging from ‘experimental status’ to 
‘effectiveness’ to ‘legitimacy of fertility as a medical indication’” (Giacomini et al. 
2000:1496).  Meanwhile, Ikonomidis and Dickens (1995:379) assert that Ontario’s 
approach may violate the Canada Health Act’s intention to “facilitate reasonable 
access to health services without financial or other barriers.”  Further, Brooks 
(1994:970) comments that “For an estimated 5% to 15% with blocked fallopian tubes, 
male infertility, endometriosis and unexplained infertility, IVF may be the only 
appropriate treatment,” but that Ontario only accounted for blocked fallopian tubes.  
Further, Giacomini, Hurley, and Stoddart (2000:1496) express unease that “medical 
necessity” was used as a sort of “Trojan horse for obscuring real decision criteria such 
as cost control” and, together with Brooks (1994), highlight the fact that the “health 
effects and social costs of alternatives such as tubal surgery, private IVF, surrogacy, 
adoption, or ‘giving up’” are not well understood (Giacomini et al. 2000:1496).  
Meanwhile, addressing the social justice debates, Brooks (1994:972) asserts that social 
currents must be acknowledged to avoid the emergence of “a two-tiered system” in 
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which “infertile patients who can afford to pay will have a chance to conceive a child” 
and “those who cannot pay will be forced to remain childless.”  Jeff Nisker (2008:426) 
further argues that Canada is “alone” amongst countries that have similar regulations 
for the ethical use of assisted reproductive technologies in its lack of public funding 
for “clinically appropriate” treatment.  Ultimately, historical events and past policy 
studies of Ontario’s debates suggests origins in the Royal Commission on New 
Reproductive Technologies, in tension with social imperatives.    
Quebec’s decision to explore IVF funding also had roots in Canada’s national 
policies.  Indeed, discussions of funding decisions arose from conversations about 
Quebec’s Bill 89 (2004), Bill 23 (2007), and Bill 26 (2009).  Each of these bills 
mandate that assisted procreation activities take place in licensed centers, that research 
be approved and overseen by an ethics committee, and—in the case of Bill 26—that 
“the assisted procreation services determined by regulation are insured services within 
the meaning of the act” (Assemblee Nationale Quebec 2009).  In fact, as later results 
outline in detail, the insurance clause was born of concerns by Members of the 
National Assembly that the province could not enforce strict regulations of 
reproductive technologies without financially supporting the procedures.   
While existing research has not yet examined the tensions underlying Quebec’s 
policy, I will use primary research to assess these debates in comparison to Ontario’s.  
This brief review of the historical factors underlying the passage of both Quebec’s and 
Ontario’s IVF funding decisions provides important context for later discussions and 
makes clear that, in both cases, conversations about the public funding of in vitro 
fertilization were initiated amidst discussions of safety and regulation.  This thesis 
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operationalizes the rationales introduced by past research into a series of concrete 
frames to track the progression of the debate and seeks to determine why the final 
decisions ultimately diverged, despite their similar roots. 
 Ultimately, it is clear that Ontario’s and Quebec’s in vitro fertilization funding 
policies have similar origins in Canada’s national context.  Further, past research 
suggests that the paths to these legislative decisions were far from straightforward and 
involved reconciling deep tensions between cost-effectiveness, medical prioritization, 
and social imperatives.  These past studies and the global debates about in vitro 
fertilization inform my research design and motivate my study about the role of the 
interactions between various stakeholders in defining IVF funding policies.  Indeed, 
existing discourse about IVF debates encourages my systematic evaluation of the 
















 As past research suggests, parliamentary debates and committee hearings are 
non-governmental stakeholders’ opportunities to intervene in political decision-
making processes.  By participating in these decision-making forums, stakeholders 
draw attention to aspects of issues that are relevant to their causes, present new 
information to politicians, and, often, insert public voice into debates (Andrews and 
Edwards 2004; Epstein 1996; Pettinicchio 2010)  While it is impossible to garner a 
complete image of behind-the-scenes conversations, examination of parliamentary 
records provides important insight into the standing of different categories of 
stakeholders in the political sphere and the influence of their framing of the issues in 
shaping problem definition and agenda-setting. 
STANDING 
Witnesses with Spoken Voice 
As shown in Table 3.1 and Figures 3.1 and 3.2, analysis of the debates leading 
up to the passage of IVF funding legislation in both provinces reveals distinct patterns 
in which stakeholders posses standing in political forums.  In Ontario, medical 
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professionals and professional associations of physicians heavily dominate debates 
surrounding Bill 50.  The Ontario Medical Association (OMA)—Ontario’s major 
professional organization for physicians—either presents spoken testimony or is cited 
by witnesses in every hearing about Bill 50.  Indeed, professional organizations—
including the OMA, Ontario Hospital Association, Sudbury and District Medical 
Society, and the College of Physicians and Surgeons of Ontario—represent 67% of all 
parliamentary witnesses appearing in Ontario’s IVF-related debates.  Meanwhile, non-
professional interest groups have a much smaller presence, comprising only 34% of 
witnesses.  Despite advocacy groups’ efforts to incorporate public voice, members of 




Table 3.1: Relative Presence of Witnesses with Spoken Voice in Parliament 
 
Ontario Quebec 
Stakeholder Type Number Percentage Number Percentage 
Medical Professional 0 0% 3 30% 
Interest Group 6 100% 6 60% 
General Health 1 17% 1 10% 
Infertility Awareness 1 17% 1 10% 
Professional Organization 4 67% 3 30% 
Women's Rights 0 0% 1 10% 
Member of the General 
Public 0 0% 0 0% 
Celebrity 0 0% 1 10% 
































































































While medical professionals maintain a strong presence in Quebec’s IVF 
funding debates, they share the stage with a wider range of stakeholders than in 
Ontario.  Medical professionals and medical professional organization each comprise 
30% of total parliamentary witnesses in Quebec.  Meanwhile, non-professional 
interest groups—including infertility awareness groups, women’s health organizations, 
and general health organizations—represent 30% of witnesses.  Celebrities also appear 
in Quebec’s hearings.  Specifically, Julie Snyder—a television star—appears as a 
witness in a meeting of the Committee of Social Affairs and represents 10% of the ten 
total witnesses appearing in Quebec’s IVF funding debates.  
Stakeholders Cited Indirectly 
While not provided the same degree of standing as those who appear as 
witnesses with spoken voice, a variety of stakeholders are represented in Parliament 
via indirect citation.  In both Ontario medical professionals comprise 25% of indirect 
citations and medical professional organizations make up 50% (see Table 3.2 and 
Figure 3.3).  Meanwhile, in Quebec, professional organizations represent 29% of 
indirect testimony.  Most notably, however, members of the public, while not given 
the opportunity to present their views directly, are quoted in politicians’ testimony.  
Indeed, members of the general public comprise 25% of indirect quotations (10% of 
overall testimony) in Ontario and 57% of citations (24% of overall testimony) in 
Quebec.  In  Quebec, politicians cite stories of a number of individuals suffering from 
infertility.  In Ontario, however, members of the public only appear as signatories on a 
petition made alongside medical professionals.  Indeed, in Ontario, members of the 





Table 3.2: Frequency of Indirect Citations in Parliament by Stakeholder Type 
 
Ontario Quebec 
Stakeholder Type Number Percentage Number Percentage 
Medical Professional 1 25% 0 0% 
Interest Group 2 50% 2 29% 
General Health 0 0% 0 0% 
Infertility Awareness 0 0% 0 0% 
Professional Organization 2 50% 2 29% 
Women's Rights 0 0% 0 0% 
Member of the General 
Public 1 25% 4 57% 
Celebrity 0 0% 1 14% 





















































FRAMING IVF FUNDING DEBATES 
Table 3.3 consolidates the ideas presented in Ontario’s and Quebec’s 
parliamentary debates into six frames.  These frames describe the dominant themes in 
discourse about public funding of IVF and serve as a crucial cornerstone for later 
discussions.  It is important to note that the pro and anti camps often deploy the same 
general frames with different spins.  
 
Table 3.3: Dominant Frames in IVF Funding Debates in Ontario and Quebec 
Frame Pro Anti 
Cost-Effectiveness Funding IVF discourages the use 
of cheaper infertility treatments, 
such as ovarian hyper 
stimulation drugs and 
discourages multiple embryo 
transfers.  This, in turn, 
decreases the risk of multiple 
births and the accompanying 
financial burdens associated 
with complicated pregnancies 
and prematurity. 
Funding IVF is extremely 
expensive and places an 
additional burden on the 
already-strained public 
health system.  The province 
does not have sufficient 
resources to fund all services 
that may be seen as 
medically necessary and 
must prioritize. 
Medical Necessity Infertility is a disease and in 
vitro fertilization is a medically 
necessary treatment required to 
treat this disease in a safe and 
appropriate manner.  Further, 
IVF reduces the prevalence of 
multiple births and the medical 
complications associated with 
complicated pregnancies and 
prematurity.  IVF also reduces 
the mental health consequences 
of prolonged infertility. 
Infertility is not a disease 
and/or it should not be 
prioritized for funding over 
other legitimate conditions 
such as cancer. 
Social Justice It is unjust that some individuals 
are able to access IVF while 
others are not.  Private funding 
of IVF creates a two-tiered 
society in which the rich can 
take advantage of fertility 
treatments while the poor 
cannot.  Infertile couples have a 
right to have access to 
appropriate treatments (IVF). 
It is unjust to use taxpayer 
dollars on a service that 
benefits only a small subset 
of the population.   
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Population Control IVF reinvigorates flagging birth 
rates by enabling those who 
previously could not have 
children to reproduce. 
IVF produces too many 
children, placing a major 
burden on a country which 
already has too few 
resources and employment 
opportunities for its current 
citizenry. 
IVF is Experimental In vitro fertilization has been 
proven effective and safe.  
Further, publicly funding the 
procedure enables government 
regulation and oversight of IVF 
because the government controls 
the money going into the 
fertility clinics. 
In vitro fertilization is still a 
relatively new treatment and 
is still experimental.  
Regulations and testing are 
necessary to ensure that the 
treatments are safe and 
effective. 
Women’s Rights Funding of IVF gives women 
the right to control whether or 
not they have children and 
reduces inherent social 
inequalities between women.  
Treating infertility with IVF 
reduces the focus on 
preventative measures and 
the causes of infertility.  
Funding should instead be 
directed toward regulation 
and ensuring that these 
procedures are safe. 
 
Framing Funding Support 
 In both provinces, the pro-funding camps rely heavily on frames of social 
justice and medical necessity to justify their positions.  While these frames are 
frequently interspersed with threads of cost-effectiveness and discussions of 
regulation, politicians, medical professionals, and advocacy organizations alike focus 
heavily on the social justice and health benefits of IVF funding.  The following 
sections break down how specific types of actors use these frames in Ontario’s and 
Quebec’s funding debates.3 
                                                 
 Ontario’s decision to defund in vitro fertilization was part of a broader piece of legislation which 
defunded a variety of medical services.  Parliamentary discussions about changes to Ontario’s Health 
Insurance Plan sought to define procedures for prioritization of medical services funding.  Therefore, 
many of the debates about Bill 50 did not relate solely to IVF.  Consequently, a chart delineating 
stakeholders’ use of various IVF funding frames (like Figures 4.3 & 4.4) cannot be constructed because 
Ontario’s debates do not solely relate to IVF and do not directly parallel their Quebecois counterparts.   
The text of this chapter provides a comprehensive review of stakeholder testimony. 
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Politicians.  In both Ontario and Quebec, politicians in support of IVF funding 
primarily deploy medical necessity and social justice frameworks to support their 
viewpoints.  In the Ontario case, where external witnesses are few and far between, 
Bill 50 opponents focus primarily on the injustice of public opinion’s absence from 
determinations of medical necessity in delisting health services.  Jim Wilson, an MPP 
from Simcoe-Grey, is the most prominent member of the opposition and asserts:  
After extensive public consultation, the state of Oregon, as honourable 
members know, has come up with a list of health care services it will 
pay for and a list of those it won't pay for.
4
  But unlike Oregon, the 
[Minister of Health] is not even consulting with the public when she 
makes her service cuts.  The minister and a group of senior civil 
servants are rationing health care behind closed doors.  It is time for the 
minister to come out of the back room and present this House with a 
list of services she has already cut and a list of services she will fund in 
the future. (Legislative Assembly of Ontario April 9, 1992) 
 
Indeed, Mr. Wilson makes clear that there is great injustice in the government’s 
delisting of services without consideration of non-governmental perspectives.  In a 
subsequent testimony, he contends: 
 ...all provincial governments are…delisting services, hoping that 
somebody like an in vitro fertilization interest group won’t take them to 
court and say, “We believe it’s medically necessary; here is the 
scientific data,” and take them all the way to the Supreme Court of 
Canada to try and prove the point that it’s a violation of the Canada 
Health Act. (Legislative Assembly of Ontario December 8, 1993) 
 
In short, proponents of in vitro fertilization funding in Ontario really manifest as 
proponents of public participation.  Rather than deploying IVF-specific frames, the 
politicians advocate on behalf of public presence in political decision-making.  
                                                 
 To determine which services qualify for inclusion in the state-provided Oregon Health Plan, the 
Oregon Health Evidence Review Commission (HERC)—which includes legislators, community 
leaders, and health professionals—prioritizes medical conditions and treatments based on “clinical 
effectiveness and cost-effectiveness.”  This Prioritized List emphasizes prevention and health education 
and therefore preferences treatments that prevent illness over those that treat existing illnesses (Goar 
1993; Oregon Health Plan n.d.). 
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 In Quebec, in contrast, a fierce cohort favors IVF funding, arguing directly 
against the Minister of Health and his supporters.  While numerous arguments are 
presented supporting the proposed legislation, they are primarily arguments about 
medical necessity and social justice.  As Eric Caire (MNA, La Peltrie) asserts, “if one 
is to speak of infertility as an illness…one must necessary ask oneself whether or not 
this illness requires treatment and whether or not this kind of treatment, like others 
which are medical procedures, should be covered by the Quebec Medical Insurance 
Board” (Quebec Committee on Social Affairs June 10, 2008).  Indeed, Mr. Caire 
draws upon a framework heavily utilized in Quebec as he argues:  
…we fail to grasp that aspect of our mission that represents those 
individuals, that represents those persons, and we abandon a huge part 
of the population, in a context where one must be consistent, no?  When 
we say that the government reimburses abortion, when we say that the 
government reimburses vasectomies and vasovasectomies and tubal 
ligations and that, when one suffers from infertility and I want to 
emphasize this word “suffers,” one is given an insignificant tax 
credit…I believe we've gone down the wrong road and have betrayed 
our fundamental mission as parliamentarians which is, first and 
foremost, to represent and speak on behalf of individuals. (Quebec 
Committee on Social Affairs June 10, 2008).   
 
Much in line with many non-government lobbyists, Caire and his supporters contend 
that the government must fund IVF because it is unjust to deem similar services 
medically necessary but exclude IVF from similar recognition and funding.  
Importantly, Caire also acknowledges his role as a representative of his constituents 
and their individual interests.  Meanwhile, Bernard Drainville (MNA, Marie-Victorin) 
presents the other dominant frame in Quebec’s debates as he contends that failing to 
fund IVF will create a two-tiered society in which the rich can afford infertility 
treatments and the poor cannot.  “The average revenue available for a family, after 
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taxes, was $55,837,” Drainville states, “Do you know many couples, Ms. President, 
who earn an average of $55,000 and who have, moreover, $10, 000 hidden in the 
bottom of a drawer  so that they can pay for in vitro fertilization?  I don’t think so” 
(Quebec National Assembly June 4, 2008).  Indeed, Mr. Drainville’s testimony is very 
much in line with the social justice frame that reoccurs frequently in IVF funding 
debates.  Together, these examples make clear that the political support in Quebec is 
very much built upon medical necessity and social justice frames. 
Medical Professionals.  In both Ontario and Quebec, physicians and their 
professional organizations appear only as proponents of public funding and as 
advocates of characterizing in vitro fertilization as a medical necessity. In Ontario, 
these doctors and professional organizations clearly assert before Parliament that Bill 
50 is unacceptable because it provides the government too much power to prioritize 
health services and to decide what publicly-funded medicare should cover.  Dr. Tom 
Dickson, President of the Ontario Medical Association, contends that “Bill 50 in its 
original form was draconian and ill conceived…The proper delivery of health care is 
too vital to this province to be sacrificed to a short-term agenda that ignored the input 
of providers in the interests of patients” (Ontario Standing Committee on Social 
Development October 19, 1993).  Similarly, the College of Physicians and Surgeons 
of Ontario opposes the bill on the grounds that it permits the government too much 
latitude in determining which services a patient may receive.  “Decisions regarding 
what medically necessary services are provided to a patient,” the College contests, 
“are the responsibility of that patient’s physician…He or she is trained to make 
judgments based on the patient’s clinical condition and needs; ministry officials are 
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not” (Ontario Standing Committee on Social Development October 19, 1993).  In 
short, medical professionals in Ontario advocate strongly for IVF funding on the basis 
of medical necessity.  Importantly, these physicians are chiefly focused on who has the 
authority to define medical necessity and on the governments’ role in the matter. 
 As in Ontario, physicians and medical professional organizations in Quebec 
primarily frame IVF funding as an issue of medical necessity, with a secondary focus 
on social justice and cost-effectiveness.  This trend first appears when MNA Louise 
Harel of Hochelaga-Maisonneuve argues that it is unjust that only those with sufficient 
funds can access IVF and then cites an Association of Obstetricians and Gynecologists 
of Quebec statement that “infertility is a medical problem and can easily be compared 
to an unwanted pregnancy, and I quote, he said: ‘We have the money for contraception 
and abortion, but not for fertility.  This is unjust’” (Quebec National Assembly April 
14, 2005).  Physicians Dr. Seang Lin Tan and Ms. Camille Sylvestre of the McGill 
University Reproductive Center echo similar sentiments and use numerical evidence 
to reinforce the message that infertility is a medical condition: 
It is important to note that infertility is an important question for it 
affects 15 percent of couples and this number is only going to increase 
because people are procreating at later and later stages of life. 
Unfortunately, it's often regarded as an insignificant medical problem, 
even though we know, according to certain studies, that infertility 
causes absenteeism in the nation, diminishes production and the 
spending of resources--it's not just depression, but moral depression. 
(Quebec Committee on Social Affairs March 28, 2006) 
 
While the doctors also draw upon cost-effectiveness and population control as 
justifications for their support of IVF funding, they ultimately conclude that the health 
benefits of increasing chances of reproductive success and reducing multiple 
pregnancies are critical factors (Quebec Committee on Social Affairs March 28, 
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2006).  The Quebec Association of Pediatricians takes a similar approach and 
advocates for IVF funding on the grounds that it will discourage the use of ovarian 
stimulation and other cheaper infertility treatments, thereby reducing multiple 
pregnancies and premature births (Quebec Committee on Social Affairs March 29, 
2006).  Moreover, the Association contends that infertility is “a health problem which 
increases in our society, under the influence of a number of factors including the 
increasing age of the women who decide to procreate” (Quebec Committee on Social 
Affairs March 29, 2006).  Further, drawing on examples of countries such as Belgium, 
Sweden, France, and England which subsidize IVF, the organization asserts that the 
aforementioned reduction of multiple pregnancies will greatly reduce both medical 
consequences and financial costs.  MM. Francois Bissonnette and Robert Hemmings, 
obstetricians specializing in reproduction, expand on the discussion of this 
intervention’s cost-effectiveness as they contend that reducing multiple pregnancies 
and utilizing reproductive technologies will fuel the global economy by diminishing 
unnecessary costs and health consequences (Quebec Committee on Social Affairs 
March 28, 2006).  Finally, the Canadian Fertility and Andrology Society (CFAS) 
argues that “the numbers prove that infertility remains a major health problem in 
Canada” and maintains that it is unjust that “couples affected by infertility are saddled 
with a significant financial burden, if their condition obliges them to seek assisted 
procreation treatments” (Quebec Committee on Social Affairs March 28, 2006).  
Overall, it is clear that the dominant frame among medical professionals is the medical 
necessity of combating infertility to reduce preventable health consequences and 
associated or indirect financial burdens. 
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Advocacy Organizations.  In both Canadian provinces, non-professional 
advocacy organizations support IVF funding through similar medical necessity and 
social justice frames.  In Ontario, the only two non-professional organizations to 
appear as witnesses are the federally-funded Infertility Awareness Association of 
Canada (IAAC) and the Patients’ Rights Association.  Each of these organizations 
appears in one meeting of the Standing Committee on Social Development and both 
unsuccessfully attempt to assert the need for public participation in defining the 
medical necessity of various services.  The IAAC, in particular, notes that “Infertility 
is a medical condition affecting one in six couples of childbearing age in Canada” and 
comments that the World Health Organization recognizes infertility as a disease and 
classifies in vitro fertilization as an important treatment for this condition (Ontario 
Standing Committee on Social Development November 1, 1993).
5
  The IAAC further 
contends that: 
The first step in de-insuring services should be to define “medically 
necessary.”…establish procedures to finalize definitions and criteria.  
Initially, the process should be a joint one with the OMA and MOH 
[Ministry of Health].  Input should then be sought from expert groups, 
for example, IAAC, as the representative of the infertile population.  
Then the public should be allowed to participate in this very important 
discussion. (Ontario Standing Committee on Social Development 
November 1, 1993) 
 
Indeed, these advocacy organizations spend much of their testimony advocating for 
the public’s right to participate in the governments’ process defining which conditions 
and medical services are medically necessary. 
                                                 
 The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the 
World Health Organization (WHO) define infertility as “a disease of the reproductive system defined 
by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual 
intercourse” in their 2009 Glossary of ART Terminology (Zegers-Hochschild et al. 2009). 
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Similarly, in Quebec, interest groups reinforce the frames of medical necessity, 
social justice, and cost-effectiveness.  Specifically, the Association of Infertile 
Couples in Quebec (ACIQ) strongly advocates for funding on the bases of medical 
necessity and cost-effectiveness.  Drawing upon personal experience with infertility, 
the ACIQ representative shares: 
There are people who say that receiving an infertility treatment does 
not cure the illness, and that one should not assume such costs.  To tell 
you, from a personal viewpoint, it is an illness.  There are people who 
fall into depression because of infertility; there are couples who 
separate because of it.  Significant percentages of couples who need to 
separate will not do so.  Such social costs are not negligible in a 
society.  So, I think that infertility is an illness and that infertility 
treatment, when it allows couples to have children, helps enormously. 
Then, if you don't have children following the treatment, well at least 
you will have tried.  You will have tried and then have the personal 
satisfaction of saying: I tried everything I could to have children. 
(Quebec Committee on Social Affairs June 10, 2008) 
 
Through this testimony, the ACIQ turns the cost-benefit discourse on its head and 
implores politicians to consider the human cost of failure to fund in vitro fertilization 
and reinforces the message that IVF is a medically necessary service.  The ACIQ 
representative further supports this claim as she argues that Quebec’s health insurance 
covers other forms of assisted reproduction—such as artificial insemination and 
ovarian stimulation—and draws upon Belgium’s success in reducing the costs and 
health consequences associated with multiple pregnancies (Quebec Committee on 
Social Affairs June 10, 2008).
6
  Overall, the ACIQ representative’s testimony 
complements physicians’ arguments and draws together issues of medical necessity 
and cost-effectiveness to encourage the government to recognize the challenges that 
infertile members of Quebec’s population face. 
                                                 
 Belgium fully funds six cycles of in vitro fertilization for women under the age of 40 (Berg Brigham 
et al. 2013). 
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Public Figures.  The presence of public figures distinguishes Quebec’s 
decision-making process from Ontario’s.  While only medical professionals, 
professional organizations, and two advocacy organizations appear in Ontario’s 
debates, celebrity Julie Snyder reinforces calls for IVF funding in Quebec through the 
story of her own battle with infertility and claims of medical necessity and social 
justice.  Snyder specifically contends that “the current policy of tax breaks in Quebec 
is no longer acceptable, for two main reasons: it obliges infertile couples whose 
financial means are limited to borrow money, which is often impossible, and thereby 
creates a huge social injustice” and it encourages “private clinics [which] have quickly 
realized that they can profit from these tax credits” to increase their fees (Quebec 
Committee on Social Affairs June 10, 2008).  Indeed, she argues that “the Quebec 
state refuses to consider infertility as an illness” and that IVF should be covered 
because similar services—such as vasectomies and tubal ligations—are included in 
Quebec’s health insurance plan (Quebec Committee on Social Affairs June 10, 2008).  
Finally, Snyder contends that IVF will save money by reducing multiple pregnancies.  
Having been invited to speak in IVF debates because of her celebrity status, Snyder 
reinforces the social justice and medical necessity frames that other stakeholders 
present. 
Members of the General Public.  Finally, while members of the general public 
never appear before Parliament, parliamentarians represent the ideas of these 
constituents through quotations and references to popular petitions.  In Ontario, near 
the beginning of the Bill 50 debates, MPP Bill Murdoch (Bruce-Grey-Owen Sound) 
presents a petition to the Legislative Assembly with approximately 1,000 signatories 
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which contends that “proposals made under the government’s expenditure control 
plan…will have a devastating impact on access to and the delivery of health care” and 
implores that the government “withdraw these proposed measures and reaffirm its 
commitment to rational reform of Ontario’s health care system” (Legislative 
Assembly of Ontario July 15, 1993).  Similarly, in the midst of Quebec’s IVF debates, 
Members of National Assembly (MNAs) present a petition signed by 196 citizens of 
Quebec imploring the government to fund in vitro fertilization (Quebec National 
Assembly February 20, 2007).  The petitioners specifically assert that reproductive 
technology funding will combat a declining birth rate and, along the same vein as Julie 
Snyder’s testimony, argue that IVF should be covered because the expansive state 
health insurance already includes abortion, tubal ligation, and vasectomy (Quebec 
National Assembly February 20, 2007).  In short, through petitions, members of the 
general public echo more prominent stakeholders in emphasizing the social justice and 
medical necessity frames. 
In Quebec, in addition to supplementing the decision-making process through 
petitions, pro-funding parliamentarians detail their constituents’ emotional and 
economic hardships to appeal to their opposition’s emotions.  For example, MNA 
Bernard Drainville, a strong proponent of government-funded IVF, cites constituent 
Annie Perreault’s financial burdens and the emotional rollercoaster that her infertility 
spawned: 
We are an infertile couple.  We have been trying, by all imaginable 
means, to have a child for eight year.  We’ve tried several treatments, 
including medication, laparoscopic surgery, uterine operations, artificial 
insemination—without success.  For five years we have been in the 
long and costly process of in vitro fertilization, doctors have told us that 
this is likely the only possibility…We have undergone five treatments 
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until now, and in total this has cost us nearly $50,000 if one includes 
the cost of accompanying medications, and the RAMQ doesn’t even 
cover the medication for in vitro fertilization, in vitro costs between 
$3,000 and $7,000 and, on top of that, you need to take into account the 
price of medicine…We mortgaged our house, exhausted our credit line.  
Just last month, we tried a sixth in vitro fertilization—our last chance 
because we no longer have the resources to do so…it’s a challenge to 
make economies and go into debt for this ultimate dream. (Quebec 
National Assembly June 4, 2008) 
 
As evidenced above, Drainville tugs on his opponents heartstrings by highlighting the 
unjust fact that these infertility sufferers have drained their savings in a number 
unsuccessful attempts to have children.  In another instance, Drainville cites 
constituent Valerie Cote who corroborates the moral imperative and social justice 
approach put forth in Ms. Pereault’s statement: 
You will surely tell me that the State gives a tax break of 50% for 
fertility treatments. I consider myself lucky to have been able to borrow 
the necessary money for my treatments.  If I had not been able to 
borrow, I wouldn't have my son to cuddle every day.  Many infertile 
couples don't have this chance.  In effect, the tax break doesn’t help 
infertile couples who don't have the means to shoulder the costs. 
(Quebec National Assembly June 4, 2008) 
 
Indeed, as these statements demonstrate, though members of the public do not speak in 
parliamentary debates, parliament members recount individuals’ personal struggles to 
advance the social justice discourse supporting IVF funding. 
 
Ultimately, IVF proponents in both Ontario and Quebec primarily center their 
arguments around medical necessity and social justice, with a secondary focus on cost-
effectiveness.  Yet, advocates in the two provinces apply the same frames quite 
differently.  In Ontario, both the social justice and medical necessity discussions are 
geared toward discussion of public involvement in decision-making.  In Quebec, in 
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contrast, stakeholders present a more multifaceted perspective and reinforce IVF-
specific messages of social justice, medical necessity, and cost-effectiveness. 
Framing the Opposition 
 Unlike the more multifaceted approach of IVF funding proponents, the 
opposition in both provinces heavily focuses on three specific frames: cost-
effectiveness, experimental risk, and the protection of women’s rights.  In both cases, 
parliamentarians comprise the majority of the opposition and emphasize the financial 
burdens that IVF funding places on the healthcare system.  Meanwhile, in Quebec, 
women’s rights organizations raise concerns about insufficient focus on preventing the 
causes of infertility and about protecting the rights of women as guardians of their 
own bodies.  The following section details the specific arguments that politicians and 
witnesses present in opposition to public funding of in vitro fertilization. 
Politicians.  In Ontario, Minister of Health Ruth Grier and her supporters are 
the primary representatives of parliamentary opposition to IVF funding.  This cohort 
advocates for Bill 50 on the grounds that cost cutting is necessary to maintain 
Ontario’s successful medicare program, as seen in Ms. Grier’s statement to the 
Legislative Assembly: 
The current fiscal situation forces us to face an inescapable truth: Our 
system is the most expensive publicly funded system in the world… If 
we keep spending as though the sky were the limit, we will not have a 
universal health care system to pass on to our children and our 
children’s children, because the system would become unsustainable. 
(Legislative Assembly of Ontario July 26, 1993) 
 
The bill, Ms. Grier continues, “is not for the purpose of allowing government to 
practise medicine…nor does it allow the government to stop paying for medically 
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necessary services…” (Legislative Assembly of Ontario July 26, 1993).  Indeed, Ms. 
Grier represents the dominant opposition view that cutting funding of in vitro 
fertilization is necessary in the interest of funding other necessary services.  Ms. 
Grier’s predecessor, the Honorable Frances Lankin, presents the other dominant view 
in Ontario’s opposition: concern about the experimental nature of IVF.  Mr. Lankin 
specifically contends that “…we have to have a health system that is based on good 
analysis of what the health outcomes of procedures are” and argues that there is a lot 
of uncertainty about “whether it is an effective procedure, whether there are good 
health outcomes of the babies that are produced with that kind of technological 
intervention” (Legislative Assembly of Ontario April 9, 1992).  In sum, Ontario’s 
parliamentary opposition embodies the negative frames of cost-effectiveness, 
prioritization, and the need for regulation of experimental techniques. 
 Meanwhile, in Quebec, Minister of Health and Social Services Phillippe 
Couillard and his backers champion the necessity of prioritization in deciding which 
health services to fund.  The opposition’s overall frame is embodied by Couillard’s 
assertion that: 
…to govern is to choose.  If we could, ladies and gentlemen, we would 
like to help all seniors, all children in difficulty, all patients in Quebec 
tomorrow, give them everything they need.  However, once again, we 
must make choices according to one’s priorities, which are, in general, 
the collective priorities of society—priorities on which we will never 
agree.  Each of us has a definition of what a society’s priorities are.  
And I would say that, for this reason, I have chosen to abandon a 
medical practice that is very fruitful and very lucrative, several years 
ago, so that I could consecrate myself to public service and thus the 
bettering of the health system. (Quebec Committee on Social Affairs 




In essence, in the opposition’s view, strategic allocation and focus on benefiting the 
general population, rather than only IVF patients, should be the driving factor behind 
IVF legislation.  This belief in assessing broader priorities defines the political 
opposition in both Ontario and Quebec. 
Interest Groups.  Very few non-governmental witnesses testify against IVF 
funding in either province.  Indeed, there is not a single Ontarian witness who 
formally testifies against public funding of IVF.  Every non-governmental witness—
whether interest group, medical professional, or member of the public—testifies in 
support of IVF funding.  While the balance is not quite as skewed in Quebec, the only 
non-political stakeholders to present testimony against IVF funding are the Council on 
the Status of Women (CSW) and the Planned Parenthood Federation of Quebec 
(FQPN).  The Council on the Status of Women does not directly address the issue of 
IVF funding, but contends that “having recourse to medically assisted procreation 
techniques should not, in any case, substitute the necessity of protecting the 
reproductive capabilities of men and women” (Quebec Committee on Social Affairs 
March 29, 2006).  The council further combats the dominance of physicians in 
defining medical necessity and argues that: 
...we believe that doctors are experts in that which concerns medical 
acts, in practices, but for a question as vast as medically assisted 
procreation, in which there are important ethical issues, we think it 
necessary to widen the scope of people responsible, to consider in this 
sector how to propose guiding frameworks, or at least to suggest such 
frameworks and perspectives which could be approached by an ethics 
committee, where there will be duly accredited centers. (Quebec 
Committee on Social Affairs March 29, 2006) 
 
The government, the CSW asserts, should protect the right of women to have a say in 
their own health services and should divert funding for infertility treatments to 
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preventing sexually transmitted infections and other causes of infertility.  Similarly, 
the Planned Parenthood Federation of Quebec advocates strongly against funding of 
IVF, arguing that funding these “burdensome, costly, inefficient and risky for the 
health of women and children” technologies detract from preventing factors leading to 
infertility, such as sexually transmitted infections and environmental risks (Quebec 
Committee on Social Affairs March 30, 2006).  In sum, women’s and patients’ rights 
organizations in Quebec—the only non-governmental witnesses to testify against IVF 
funding—rely heavily on the negative frames of women’s rights and public health. 
 
 Overall, government figures advocating against IVF funding due to 
experimental risks and financial concerns heavily dominate the opposition in both 
provinces.  That said, the non-government actors who do appear before Parliament add 
some diversity to Quebec’s opposition argument as they rely primarily on frames of 
women’s rights and public health concerns. 
CONCLUSION 
Ultimately, the predominance of medical professionals as witnesses in 
Ontario’s debates about Bill 50 constructs the discussion of medical funding—and of 
IVF funding specifically—as a debate about medical necessity.  When considering this 
conclusion, it is important to note the relatively low number of parliamentary records 
analyzed (16 from Ontario, 21 from Quebec) and the fact that the IAAC was the only 
witness to testify explicitly about in vitro fertilization.  All other stakeholders 
discussed in this analysis testified more broadly about all of the medical funding cuts 
associated with Bill 50.   Nonetheless, consideration of all testimony makes clear that 
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the Ontarian Parliament’s hearings about the 1993 Expenditure Control Plan Statute 
Law Amendment Act are essentially debates about who has the authority to define 
medical necessity.  Supporters of the bill—namely Minister of Health Ruth Grier—
argue on the basis of cost-effectiveness and the need to cut expenses given limited 
health funding.  Meanwhile, the overwhelming dominance of medical professionals 
and medical professional organizations as witnesses ensures that the government-
physician power struggle, rather than issues of social justice or women’s rights, is 
central to medical funding decisions.  Meanwhile, patient advocacy organizations such 
as the IAAC attempt to introduce public opinion in defining medical necessity, but are 
at the mercy of more prominent players.  In the case of Ontario’s 1993 Expenditure 
Control Plan Statute Law Amendment Act, the relative absence of non-professional 
interest groups appears to have enabled massive cuts and physician-dominated debates 
about medical necessity. 
In Quebec, in contrast, IVF funding debates involve a greater balance between 
politicians, medical professionals, and other stakeholders.  Though the government 
opposition relies on similar frames of prioritization and cost-effectiveness, the 
proponents of IVF funding present a more multifaceted argument.  Indeed, discussion 
topics ranging from the cost-effectiveness and medical necessity of treating infertility 
to the social justice issues related to unequal access overwhelm the opposition’s 
argument that funding IVF would place an undue burden on Quebec’s health system.  
Ultimately, it seems that the diversity of stakeholders and the bill proponents’ 
multifaceted approach is an important factor distinguishing Quebec’s decision-making 













While examination of parliamentary records provides important insight into 
stakeholder standing in government forums, media coverage analyses lend insight into 
the image presented to members of the general public.  Indeed, newspaper coverage 
plays a critical role in shaping public perspectives of political processes and is the only 
forum through which members of the general public are able to voice their views (E. 
Baker 1998; McCombs and Shaw 1972; Rosen 1996).  As such, consideration of 
stakeholders’ relative standing in news media coverage and framing of the funding 
issue in this arena plays a critical role in assessing whose perspectives are considered 
important in shaping problem definition and which stakeholders have the political and 
financial resources to gain traction in the public sphere. 
STANDING  
Examination of media coverage of Ontario’s 1993 Expenditure Control Plan 
and Statute Law Amendment Act and Quebec’s 2008 decision to incorporate in vitro 
fertilization into its health care plan suggests notable patterns in which stakeholders 
have a voice in debate media coverage.  Interestingly, the relative standing of different 
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stakeholders varies significantly from standing in the previously discussed 
parliamentary hearings and debates. 
 As in the aforementioned case of parliamentary hearings, politicians and 
interest groups comprise a large majority of stakeholders quoted in media sources.  As 
Table 4.1 and Figures 4.1 and 4.2 show, politicians in Ontario represent 39% of 
overall stakeholder quotations and tie interest groups for the largest proportion of 
utterances.  In Quebec, politicians are the most quoted group of stakeholders and 
represent 22% of stakeholders cited in media testimony.   
 Interestingly, medical professionals and professional organizations maintain a 
less dominant role in media coverage than in parliamentary debates.  In Ontario’s 
coverage, medical professionals and medical professional organizations each comprise 
11% of citations.  In Quebec, medical professionals put forth 17% of utterances, while 
medical professional organizations expressed 7%.  In short, while medical 
professionals and their professional organizations maintain a strong presence, they are 
not as overwhelmingly dominant as in parliamentary debates and committee hearings.  
 Potentially the most interesting discrepancies between news media and 
parliamentary standing are the relative presences of non-professional interest groups, 
academics, celebrities, and members of the general public.  While the celebrity 
presence remains approximately the same—Quebec’s Julie Snyder represents 12% of 
citations and remains the only celebrity to speak on the issue—there are notably more 
quotations by academics and members of the public and fewer by advocacy 
organizations.  In Ontario’s media coverage, academics—who did not have standing in 
parliamentary debates—comprise 4% of quotations.  Meanwhile, members of the 
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public—who appeared in parliament only via indirect citations—represent 7%.  
Similarly, in Quebec’s coverage, academics represent a significant 13% of media 
quotations and members of the general public are cited nearly as many times as 
interest groups at 17%.  Finally, non-professional interest groups—namely infertility 
awareness organizations, patient advocacy groups, and women’s rights 
organizations—represent 29% of overall citations in Ontario and 13% of utterances in 
Quebec, a smaller presence than they had in parliamentary debates.  Indeed, while it is 
important to note that the comparison is not perfect because politicians were not 
included in calculations of parliamentary debate standing and because fewer debate 
records than media records were available for analysis, the considerable differences in 
the relative presence of stakeholders in these two cases presents important insight into 
the influence of various actors in different political decision-making forums. 
 
Table 4.1: Relative Presence of Stakeholders in Media 
Stakeholder Appearances in News Media 
  Ontario Quebec 
Stakeholder Type Number Percentage Number Percentage 
Politician 11 39% 13 22% 
Medical Professional 3 11% 10 17% 
Interest Group 11 39% 12 20% 
General Health 1 4% 0 0% 
Infertility Awareness 3 11% 8 13% 
Professional Organization 3 11% 4 7% 
Women's Rights 4 14% 0 0% 
Academic 1 4% 8 13% 
Celebrity 0 0% 7 12% 
Member of the General Public 2 7% 10 17% 





























































































Framing Funding Support 
 Analysis of media coverage of IVF funding debates in both Ontario and 
Quebec suggest that the social justice and medical necessity frames which dominated 
the parliamentary hearings are also the predominant factors in media coverage (see 
Tables 3.3 & 4.2 and Figure 4.3).  While these frames are interspersed with 
discussions of cost-effectiveness, women’s rights, and population control, there is a 
heavy emphasis on infertility as a disease and on the unjust nature of unequal access to 
IVF services.  The following section dissects how specific actors utilize each of these 
frames in both Ontario and Quebec. 
Politicians.  Politicians play vastly different roles in the media coverage of 
Ontario’s and Quebec’s decision-making processes.  In Ontario, virtually every 
politician cited in newspaper coverage represents the opposition.  Indeed, the only 
mention of a politician who is even remotely in support of IVF funding is a mention 
that liberal leader Lyn McLeod “slammed [Health Minister] Grier for holding only 
one day of public hearings on a proposal to cut 19 medical services from OHIP” 
(Anon 1993b).  In Quebec, in contrast, political figures represent a larger diversity of 
opinions and present a greater variety of frames.  Political IVF funding proponents 
particularly focus on issues of population control, with secondary focuses on medical 
necessity, cost-effectiveness, and social justice issues.  In multiple instances, figures 
such as Premier Jean Charest express optimism that funding in vitro fertilization 




























































































Charest supplements his assertions with acknowledgment that IVF is a medically 
necessary treatment and Minister of Health Yves Bolduc (the successor of previously 
mentioned Health Minister Philippe Couillard) expresses optimism that the policy will 
cut costs associated with multiple pregnancies. 
Medical Professionals.  As in the parliamentary hearings and debates, medical 
professionals and their professional organizations are cited primarily as IVF funding 
proponents.  In Ontario, the majority of these medical professionals and professional 
organizations deploy frames of medical necessity and assertions that there must be 
checks and balances in defining this term.  While the Medical Director of Ottawa 
Civic Hospital’s IVF center cites population control as a benefit of IVF funding, the 
majority of medical professionals’ or organizations’ quotations express concerns, 
similar to those expressed in Parliament, that the proposed Bill 50 “could give 
bureaucrats the power to dictate when, why, how and where patients get treated” 
(Anon 1993c).  In the Quebec case, medical professionals and representatives of 
professional organizations advocate for IVF funding primarily based on medical 
necessity, with an additional emphasis on population control.  Seang Lin Tan of the 
McGill Reproductive Centre states that one in eight Canadian couples struggles with 
infertility (Krashinsky 2009), while others, such as the Canadian Fertility and 
Andrology Society, assert that funding IVF will reduce major public health concerns 
such as multiple pregnancies and premature birth.  In sum, as in parliamentary 
testimony, medical professionals and medical professional organizations primarily 
support IVF because they consider infertility a disease and IVF a medically necessary 
treatment to treat the condition and reduce its public health consequences. 
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Interest Groups.  Interest groups also retain their strong presence as funding 
proponents.  As in the parliamentary debates, the vast majority of interest groups are 
cited as IVF funding supporters.  In Ontario’s case, interest groups’ quotations 
primarily represent the Infertility Awareness Association of Canada (IAAC) or the 
Ontario Medical Association (OMA).  As indicated in Chapter 3, the OMA argues 
against Bill 50 in support of public and medical professional involvement in defunding 
decisions.  The IAAC focuses primarily on social justice and medical necessity 
frameworks and advocates for IVF funding on the grounds that infertility is a medical 
condition for which IVF is a proven treatment.  Indeed, one quote contends that “the 
tax dollars of the infertile pay for reproductive health care for the fertile” (Papp 1994), 
while another asserts that the IAAC is disturbed that the “government considers IVF to 
be some sort of esthetic frill; that one can somehow choose infertility as one would 
choose to get a tattoo” (Anon 1993a).  In Quebec, non-professional interest groups 
support IVF funding with a range of frames.  Organizations such as the IAAC 
primarily emphasize the medical necessity of IVF—as seen in executive director 
Beverly Hanck’s statement that infertility is a “serious medical condition with 
economic, social and personal consequences” (Fidelman 2010).  However, these 
organizations also pinpoint factors such as the potential for a reduced burden of 
multiple pregnancies and the social justice benefits of universal IVF access.  Overall, 
interest groups supplement the perspective of medical professionals as they reinforce 
messages of medical necessity and emphasize the public health benefits associated 
with public funding of in vitro fertilization. 
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Public Figures.  Like in parliamentary debates, the only public figure to appear 
in media-based IVF funding debates in either province is Julie Snyder, who plays a 
prominent role in the discourse and draws on social justice frames to assert her support 
for IVF funding.  In a number of instances, Snyder draws on the public’s empathy and 
sense of justice as she questions why others should not be able to access the services 
that enabled her to have a family.  “There are some people who can only afford one 
treatment,” Snyder remarks, “so you cry with them…It’s deeply unfair.  I promised 
God that if I had my baby I’d do my best to help others” (Wente 2010).  It is unjust, 
Snyder reasons, that only Quebecois citizens who have financial resources can access 
this important tool in combating infertility.  Indeed, this celebrity provides a level of 
high-profile reinforcement for pro-funding frames that was notably absent in Ontario. 
Academics.  Academics represent a more significant percentage of utterances 
in media coverage of IVF funding debates than they do in parliamentary hearings.  
Yet, academics still make a limited number of appearances overall and generally 
appear as IVF funding opponents.  In fact, in Ontario, only one pseudo-academic 
appears in debate media coverage.  In this instance, Kirsten Kozolanka, who wrote a 
university thesis about infertility, comments that women “have mutilated 
bodies…through their pursuit of infertility” and that in vitro should be funded to 
reduce this phenomenon (Pigg 1990).  In Quebec, however, academics are more 
frequently quoted in support of IVF.  Specifically, New Scientist magazine cites 
“flagging birth rates” as an incentive for IVF funding (Rinehart 2007) while Jeff 
Nisker calls upon a social justice frame and rhetoric of inequality to justify his claims.  
65 
 
In sum, though they do not comprise a large proportion of stakeholders, academics are 
often cited by writers to validate frames presented by other stakeholders. 
Members of the General Public.  Members of the general public have a 
stronger voice in media coverage than they do in parliamentary debates in either 
province.  In Ontario, an article quoting results from a telephone poll represents 
members of the general public.  While 71% of callers state their opposition to 
including IVF in the Ontario Health Insurance Plan (OHIP), the 29% in support of 
inclusion cite frames of social justice—commenting that “OHIP should cover those 
who are unlucky and can’t have children for any reason”—and arguments that IVF 
will spur the province’s birth rate (Turner 1993).  Meanwhile, in Quebec, members of 
the general public appear primarily in personal testimonies used as introductions and 
“hooks” for both news and editorial pieces.  As they describe the emotional and 
financial strains wrought by their hard-fought battles against infertility, these members 
of the general public draw upon frames of social justice and medical necessity to 
justify their cause.  For example, Michel Kriaa and Josee Goupil state that they have 
spent $23,000 on fertility treatments and comment that they know many others who 
have had to borrow the money for IVF (Fidelman 2010).  Overall, in both provinces, 
members of the general public represent a minority of cited stakeholders, but echo 




Framing the Opposition 
 As in parliamentary hearings, IVF funding opponents primarily deploy frames 
of cost-effectiveness and the need to prioritize medical necessities in media 
quotations.  Indeed, while a variety of stakeholders present these frames and 
supplement them with concerns about women’s rights and about the experimental 
nature of IVF, the overwhelming negative view is a fear that funding IVF will detract 
from sufficiently funding other medically necessary services.  The following section 
outlines the specific arguments various stakeholders present to challenge IVF funding. 
Politicians.  Politicians cited in media coverage of both provinces’ debates 
argue against IVF funding almost exclusively on the grounds of cost-effectiveness and 
prioritization (see Table 3.3, Table 4.2, and Figure 4.4).  In Ontario, a number of 
politicians state that defunding IVF is necessary for the OHIP’s long-term 
sustainability.  Individuals ranging from Minister of Health Ruth Grier to Treasurer 
Floyd Laughren assert that IVF is an experimental procedure that should not be 
prioritized over other medically necessary conditions and argue that financial 
necessity—rather than a desire to diminish the authority or rights of physicians, 
members of the public, or other stakeholders—requires that they take the proposed 
cost-cutting measures (Anon 1993c).  Interestingly, though these politicians 
acknowledge funding proponents’ concerns that they are excluding other stakeholders’ 
opinions in defining medical necessity, they contort these concerns to legitimate their 
own arguments and assert that representation in defining medical necessity is not the 
issue at hand.  While Quebec’s media coverage includes only two instances in which a 
politician speaks out against IVF funding, both embody an argument similar to that 
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presented in Ontario.  Specifically, politicians contend that the procedure is expensive, 
has a high failure rate, and should not be prioritized over more serious health concerns 
(Aubin 2008; Marsden 2008).  Further, Health Minister Philippe Couillard argues that 
“infertility is not an illness and that illness is the only thing for which the agency that 
handles medical bills ought to pay—the agency’s name, after all, is Regie de 
l’assurance maladie” (Aubin 2008).  In sum, in both cases, government opponents of 
IVF funding directly refute claims of medical necessity and primarily base their public 
opinions on frames of cost-effectiveness and the experimental risk. 
Medical Professionals.  Notably, medical professionals make virtually no 
comments to the media in opposition to IVF funding in either Ontario or Quebec.  
While a number of medical professionals cited in Ontario’s coverage address their 
desires to have input in the funding prioritization process, the only mention of a 
medical professional who may oppose IVF is a comment by Dr. Michael Wyman, 
vice-president of the OMA, who argues that “the concept of everything to everybody, 
anytime will have to change because the system just can’t afford all of that” (Priest 
1993).  The “system will go bankrupt” if health care applies to “everyone, 
everywhere,” Wyman argues, so services must be prioritized based on necessity 
(Priest 1993).  In Quebec, no medical professionals speak out in the news media 






























































































Interest Groups.  The only interest groups to testify in opposition of IVF 
funding in media coverage of either province’s debates are Planned Parenthood of 
Canada and the National Action Committee on the Status of Women.  Both 
organizations appear in media coverage of Ontario’s debates about Bill 50 to argue on 
the basis of women’s rights and preventative health services.  Specifically, Planned 
Parenthood of Canada advocates for prevention and health education, while the 
National Action Committee on the Status of Women calls IVF a “failed technology 
[that] has serious dangers for both women and the children that they bear” (Anon 
1993b).  In sum, as in the case of parliamentary testimony, the only interest groups to 
testify against IVF funding argue in favor of protecting women’s rights and focusing 
on preventative services. 
Academics.  Academics in both provinces reinforce the messages politicians 
present as they advocate for cost-effectiveness and prioritization in funding medical 
services.  In Ontario, the only anti-IVF funding utterance by an academic is a 
refutation by Will Kymlicka of the University of Ottawa Department of Philosophy 
who argues against  the attitude that “any new medical procedure should be 
immediately included in the health-care system, even before its safety and efficacy 
have been established” (Kymlicka 1993).  Similarly, only one academic—Abby 
Lippman, an epidemiologist and women’s health advocate—speaks on behalf of the 
opposition in Quebec’s media coverage.  Across multiple articles, Lippmann 
consistently questions why IVF should “take precedence for scarce government 
dollars over items like Quebec’s over-burdened daycare system or lack of midwives 
and family physicians” (Blackwell 2010).  In short, in both cases, academic opponents 
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of IVF funding—though few in numbers—reinforce the ideas that the government 
presents and represent a unique perspective that was absent from parliamentary 
sessions.   
Members of the General Public.  Finally, in media coverage, members of the 
general public present important support for the opposition cause.  While the only 
members of the general public represented in parliamentary testimony were IVF 
funding proponents, media coverage highlights both sides of public opinion.  As 
previously mentioned, a poll in Ontario cites members of the general public and notes 
that 2,319 callers (71%) oppose OHIP coverage of in vitro fertilization (Turner 1993).  
The article further delineates their rationales, which focus primarily on frames of cost-
effectiveness and prioritization of medical necessities.  Respondents’ statements range 
from an assertion that IVF should not be covered “because it’s not life threatening” to 
a comment that “if couples want children badly enough they should be able to find 
their own money to pay for it” (Turner 1993).  Indeed, the public voice represents a 
spectrum of frames in media coverage of Ontario’s debates.  Meanwhile, members of 
the general public in Quebec appear a number of times in opposition to IVF funding.  
Notably, a summary of readers’ online opinions highlights concerns ranging from 
“Seriously?  This is the priority?  Are you kidding me?” to “trying so long to conceive 
without success must be very difficult mentally and emotionally, as are a lot other 
things…” (Anon 2010).  In both cases, media presents the only opportunity for direct 
public input.  However, in both cases readers speak out only through indirect forums 
such as surveys or online forms.  Overall, though their relative presence is low 
compared to other stakeholders’, comments by members of the general public confirm 
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that they are generally in agreement with the interest groups, politicians, and medical 
professionals who claim to represent their interests. 
CONCLUSION 
 By and large, trends in standing and framing are fairly consistent in news 
media and parliamentary debates.  In Ontario, although a greater diversity of 
stakeholders is represented than in parliamentary hearings, medical professionals, 
professional organizations, and politicians maintain their dominant positions and 
advocate primarily for comprehensive reviews of medical necessity and analyses of 
cost-effectiveness, respectively.  Interestingly, however, women’s rights 
organizations—who were notably absent in parliamentary testimony—appear in news 
media coverage and advocate against IVF funding in defense of women’s freedom 
and preventative services.  Meanwhile, public opinion—which was absent from 
parliamentary hearings—is cited directly and is used quite explicitly to draw upon 
readers’ emotions.  Overall, Ontario’s media coverage highlights a more 
heterogeneous sample of both stakeholders and frames than the province’s 
parliamentary discussions. 
 In Quebec, the previously observed balance between politicians, medical 
professionals, and other stakeholders remains fairly consistent.  While interest groups’ 
and politicians’ statements are the majority of utterances, an array of actors—ranging 
from academics to members of the public—appear in media coverage.  Though its 
various stakeholders present a number of rationales, Quebec’s media coverage is much 
more skewed in support of IVF funding than is Ontario’s.  Indeed, despite its more 
heterogeneous pool of actors, Quebec’s coverage represents a much less balanced 
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perspective on the issue of IVF funding.  Overall, though the evidence is fairly  one-
sided, Quebec’s media coverage reaffirms the conclusion that the Quebec’s diverse 















This thesis began with a puzzle: given their similar national contexts, why did 
Quebec choose to fund IVF for all of its citizens while Ontario did not?  In light of this 
dilemma, I set out to examine the factors and processes underlying Ontario’s and 
Quebec’s divergent funding decisions.  I specifically sought to determine how relevant 
stakeholders shaped policy outcomes and whether the interaction between advocates 
and professional witnesses played a role in defining these two distinct results.  Prior 
research has suggested a decline in professional dominance in political decision-
making, particularly with respect to science and medicine, and a rise in the credibility 
and standing of lay experts (Davis and Abraham 2010; Epstein 1995, 1996; Eyal and 
Buchholz 2010).  Indeed, previous works suggested that advocates gain traction by 
asserting their roles as representatives for the general public and by deepening their 
understandings of technical terminology and concepts to gain access to government 
circles and advisory sessions (Epstein 1995, 1996).  The findings of the current study 
tend to support these claims. 
Analysis of parliamentary and media records from Ontario suggests that 
medical professionals are still very much the dominant players in IVF funding 
decisions.  In parliament, the overwhelming predominance of medical professionals as 
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witnesses turned debates about IVF funding cuts into arguments between professionals 
and government officials about professional expertise and the legitimacy of 
government intervention.  The near-absence of non-professional stakeholders—only 
two non-professional organizations testified in Ontario’s parliamentary hearings about 
Bill 50—exaggerated this dynamic.  Ultimately, though the Infertility Awareness 
Association of Canada and a few Members of Parliament hint at the need for public 
participation in the prioritization of medical services, Ontario’s parliamentary 
transcripts suggest that medical funding decision-making is still very much an issue of 
professional opinion versus government constraints. 
Media coverage of Ontario’s IVF debates represents a larger array of 
stakeholders, though medical professionals and professional organizations remain 
among the most-cited non-governmental stakeholders.  Meanwhile, the frames of 
medical necessity and cost-effectiveness remain dominant across a variety of 
stakeholder appearances, though social justice also comes into play.  Importantly, 
public opinion appears for the first time in media utterances, with writers frequently 
directly citing personal stories of infertility-suffers, often to draw upon their readers’ 
emotions.  This finding is much in line with previous research suggesting that 
encouraging narrative and personal stories breaks the boundaries between the public 
and the personal and, in so doing, encourages citizens to engage politically (Ferree et 
al. 2002:284–285).  In short, the current findings agree with past assertions that 
individuals without previous allegiances are engaged through emotional or moral 
shocks.  Overall, media coverage from Ontario suggests that the media is the forum in 
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which different forms of expertise truly mix and where the opinions of the public have 
their one chance to be directly represented.   
Meanwhile, in agreement with recent literature in the sociology of expertise, 
Quebec’s IVF funding debates represent a more balanced perspective.  Though 
government officials in Quebec still frame IVF as an issue of prioritization and cost-
effectiveness and medical professionals maintain a prominent role as experts in the 
debates, a number of lay experts appear as both advocates and opponents of the 
initiative.  Just as Epstein’s (Epstein 1995, 1996, 2007) works suggest, advocacy 
organizations such as the Infertility Awareness Association of Canada deploy medical 
terminology and technical expertise to reinforce the ideas that other stakeholders 
present.  These laypeople reinforce ideas of medical necessity and prioritization, while 
also introducing frames such as social justice and women’s rights.  Ultimately, it is 
this diversity of stakeholders that distinguishes Ontario’s legislative processes from 
Quebec’s. 
 The balance between professional and non-professional advocates remains 
fairly constant in media coverage of Quebec’s debates.  Interest groups and politicians 
represent the majority of citations, but academics, members of the general public, 
public figures, and medical professionals join in on testimony.  These actors present 
frames ranging from the importance of social justice issues to issues of cost-
effectiveness to the need for population control.  As in Ontario, writers primarily 
deploy members of the general public to enhance social justice discourses and draw on 
readers’ emotions.  On the whole, Quebec’s media coverage is quite one-sided, as 
nearly all of the cited stakeholders argue in favor of IVF funding, but it reinforces the 
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idea that a combination of professional expertise and lay expertise enhances the 
diversity of a debate and tempers the dominance of medical professionals and 
discussions of medical necessity. 
 Overall, my findings reinforce the view that advocates earn credibility and 
standing in policy debates by studying and deploying the language of experts and by 
presenting themselves as the conduits for the general public.  In addition, my findings 
support the suggestion that a diversity of stakeholders may lead to more liberal 
policies (Epstein 1996), as seen in the contrast between Ontario and Quebec.  
However, the continued struggle between professionals and politicians in both 
provinces certainly confirms that the transition to lay expertise is not simple and that 
doctors and government officials are not entirely receptive to this change.  While 
Ontario’s and Quebec’s IVF funding debates clearly represent what Epstein 
(1996:349) terms “democratization struggles in the biomedical sciences and health 
care,” they also confirm that this struggle is far from over.  In both cases, the public 
continues to fight for a voice while medical professionals and formal organizations 
maintain their stronghold over medical expertise and representation in parliamentary 
discussions. 
 In addition to corroborating claims about the interaction between professional 
and lay expertise, this thesis confirms past studies’ findings about the methods and 
impact of interest groups and of lay experts in political processes.  First, my findings 
corroborate past claims about the relationality of arguments used in political forums 
(Ferree et al. 2002).  In essence, frames do not exist in a vacuum but are instead often 
crafted using opposition arguments as their foundations (Best 2012; Ferree et al. 
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2002).  As a result, as was clearly evident in this study, concepts—such as the need for 
prioritization in funding medical services—are often used on both sides of an 
argument.  In short, stakeholders shape not only policies that are directly of interest to 
their beneficiaries, but political discourse more broadly, as they present arguments in 
support of their intended outcomes.  Further this study reinforces Best’s (2012) finding 
that advocacy organization may have impacts beyond direct benefits for their 
constituents.  Though the small number of records available for examination and the 
relatively short timeframe studied limit the explanatory power of my findings, my 
research highlights the constant tension between the interests of taxpayers at large and 
the interests of infertility disease patients—a finding that agrees with Best’s (2012) 
assertion that shifts in the perceived beneficiaries of policies may alter policy 
outcomes.  Indeed, one of the distinguishing features between Ontario and Quebec 
seems to be that disease patients were prioritized in Quebec while a broader 
constituency was favored in Ontario’s prioritization-based decision.  In addition, my 
findings suggest a relative lack of public presence in parliamentary forums as 
compared to public standing in the media.  This finding confirms the essential role of 
the media in enhancing public presence in political debates and reinforces the view 
that the media is essential to democracy (Ferree et al. 2002; McCombs and Shaw 
1972; Pettinicchio 2010).  Overall, this study reinforces past assertions about the far-
reaching impacts of advocacy initiatives and the importance of non-governmental 
forums in providing space for public input in political debates. 
 Having analyzed the courses of IVF funding debates in Ontario and Quebec, it 
is important to turn to broader applications of the concepts uncovered in this thesis.  
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Continuing this study beyond the boundaries of Quebec and Ontario would create an 
important context for future debates across North America and the Western World.  
Further, while my results suggest that one of the key factors distinguishing Quebec’s 
funding decision from Ontario’s is the heterogeneity of stakeholders represented in 
Quebec’s debates, it would be interesting to perform a more quantitative analysis of 
stakeholder standing and framing encompassing a broader time period and larger 
group of issues to further examine this inclination in a causal and systematic way.  In 
addition, while my results provide an in-depth examination of standing and framing by 
a variety of institutional stakeholders, to better understand the standing and influence 
of members of the general public, it would be informative to examine the mechanisms 
available for members of the general public to interact with and convey ideas to their 
advocates.  Finally, these results provide a strong groundwork for an examination of 
the factors underlying state funding of other controversial procedures—such as 
abortion, stem cell research, and adoption.  Policies on these procedures define a 
state’s stance on whether its citizens have a right to reproduction, at what cost, and at 
the expense of what other services.  It would be fascinating to further examine the 
dueling role of advocates and professionals in shaping funding decisions about these 
similarly high stakes procedures which lie at the crossroads of ethical issues, human 
rights discourse, and practical constraints. 
 While moral and ethical lines continue to be drawn and the credibility of lay 
experts in medical funding decision-making is continuously evolving, it is clear that 
advocates play a critical role as channels for public opinion and maintain a system of 
checks against government officials and medical professionals.  Ultimately, though the 
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applicability of these results to other contexts must be further explored, it is clear that 











Coding Instrument: Parliamentary Records 
 
1) Debate Identification: 




b. Date of debate or committee hearing 
1. Day 
2. Month  
3. Year 
 
c. In which committee or assembly did this conversation occur? 
1. Quebec National Assembly 
2. Quebec Committee on Social Affairs 
3. Quebec Committee on Health and Social Services 
4. Quebec Committee on Public Finance 
5. Ontario Legislative Assembly 
6. Ontario Standing Committee on Social Development 
7. Ontario Standing Committee on the Legislative 
Assembly 
 
2) Stated purpose of debate or committee hearing: 
 
3) Actor #_ 
a. Actor type 
1. Politician 
2. Medical professional 
3. Interest group 




b. If the actor is an interest group, which type of interest group? 
1. Infertility  
2. General health 
3. Professional organization (ex. Society of Obstetrics and 
Gynecologists of Canada) 
4. Women’s Rights 
 








e. If the actor is NOT quoted with spoken voice, who references the 
actor? 
1. Politician 
2. Medical professional 
3. Interest group 




f. Does actor #_ support public funding of in vitro fertilization? 
1. Yes 
2. No  
3. Unclear/Neutral 
4. Cannot determine 
 
g. If YES to #3b, how does the actor frame their support for IVF funding? 
(primary) 
1. Cost-Effectiveness 
2. Infertility is a disease 
3. IVF is a medical need 
4. Infertility is a public health concern 
5. IVF is a human right 
6. Health inequalities are inequitable 
7. IVF will increase the country’s total fertility rate 
 
h. If YES to #3b, how does the actor frame their support for IVF funding? 
(secondary) 
1. Cost-Effectiveness 
2. Infertility is a disease 
3. IVF is a medical need 
4. Infertility is a public health concern 
5. IVF is a human right 
6. Health inequalities are inequitable 
7. IVF will increase the country’s total fertility rate 
LEAVE BLANK IF NONE STATED 
 
a. If the debate does not focus directly on IVF, how does the actor frame 
their support for the legislation?   
1. Cost-Effectiveness 
2. Will not cut medically necessary services 




i. In general, who does the speaker cite as the primary “winners” or 
“losers” from public funding of IVF? (primary) 
1. General public 
2. Disease patients 
3. Medical professionals 
4. Government 
5. Interest groups 
 
j. In general, who does the speaker cite as the secondary “winners or 
losers” from public funding of IVF? (secondary) 
1. General public 
2. Disease patients 
3. Medical professionals 
4. Government 
5. Interest groups 
LEAVE BLANK IF NONE STATED 
 
k. If NO to #3b, how does the actor frame their opposition to IVF 
funding? (primary) 
1. Cost-Effectiveness 
2. Infertility is not a disease 
3. IVF is not a medical need 
4. Infertility is not a public health concern 
5. Publicly-funded IVF may lead to other public health 
concerns 
6. IVF is not a human right 
7. Health inequalities are not inequitable 
8. IVF is experimental 
9. Public funding of IVF threatens the rights of women 
 
l. If NO to #3b, how does the actor frame their opposition to IVF 
funding? (secondary) 
1. Cost-Effectiveness 
2. Infertility is not a disease 
3. IVF is not a medical need 
4. Infertility is not a public health concern 
5. Publicly-funded IVF may lead to other public health 
concerns 
6. IVF is not a human right 
7. Health inequalities are not inequitable 
8. IVF is experimental 
9. Public funding of IVF threatens the rights of women 





m. If the debate does not focus directly on IVF, how does the actor frame 
their opposition to the legislation?   
1. Cost-Effectiveness 
2. Too much government power to define medical 
necessity 
3. Physicians will cut services if government does not pay 
LEAVE BLANK IF NONE STATED 
 
n. In general, who does the speaker cite as the primary “winners” or 
“losers” from the prevention of IVF funding? (primary) 
1. General public 
2. Disease patients 
3. Medical professionals 
4. Government 
5. Interest groups 
 
o. In general, who does the speaker cite as the primary “winners or losers” 
from the prevention of IVF funding? (secondary) 
1. General public 
2. Disease patients 
3. Medical professionals 
4. Government 
5. Interest groups 
LEAVE BLANK IF NONE STATED 
 





Coding Instrument: Newspaper Articles 
 
1) Article Identification: 




c. Date Published 
1. Day 
2. Month  
3. Year 
 
d. The article was published in which newspaper? 
1. Globe and Mail 
2. Montreal Gazette 
3. Toronto Star 
 
e. Section and page number: 
i. The article was published in which section? 
1. News 
2. Editorial/Opinion 
3. Globe Life 
4. Focus 




ii. The article was published on which page? 
 
2) Writer Bias: 
a. Does the writer of the article support public funding of in vitro 
fertilization? 
1. Yes 
2. No  
3. Unclear/Neutral 
4. Cannot determine 
 
b. If YES to #2a, how does the author frame their support for IVF 
funding? (primary) 
1. Cost-Effectiveness 
2. Infertility is a disease 
3. IVF is a medical need 
4. Infertility is a public health concern 
5. IVF is a human right 
6. Health inequalities are inequitable 
7. IVF will increase the country’s total fertility rate 
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c. If YES to #2a, how does the author frame their support for IVF 
funding? (secondary) 
1. Cost-Effectiveness 
2. Infertility is a disease 
3. IVF is a medical need 
4. Infertility is a public health concern 
5. IVF is a human right 
6. Health inequalities are inequitable 
7. IVF will increase the country’s total fertility rate 
LEAVE BLANK IF NONE STATED 
 
d. If NO to #2a, how does the author frame their opposition to IVF 
funding? (primary) 
1. Cost-Effectiveness 
2. Infertility is not a disease 
3. IVF is not a medical need 
4. Publicly-funded IVF may lead to other public health 
concerns 
5. IVF is not a human right 
6. Infertility is not inequitable 
7. IVF is experimental 
8. Public funding of IVF threatens the rights of women 
 
e. If NO to #2a, how does the author frame their opposition to IVF 
funding? (secondary) 
1. Cost-Effectiveness 
2. Infertility is not a disease 
3. IVF is not a medical need 
4. Publicly-funded IVF may lead to other public health 
concerns 
5. IVF is not a human right 
6. Infertility is not inequitable 
7. IVF is experimental 
8. Public funding of IVF threatens the rights of women 
LEAVE BLANK IF NONE STATED 
 
f. In general, who does the author cite as the primary “winners” or 
“losers” from public funding of IVF? (primary) 
1. General public 
2. Disease patients 
3. Medical professionals 
4. Government 
5. Interest groups  
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g. In general, who does the author cite as the primary “winners or losers” 
from public funding of IVF? (secondary) 
1. General public 
2. Disease patients 
3. Medical professionals 
4. Government 
5. Interest groups 
LEAVE BLANK IF NONE STATED 
 
3) Actor #_ 
a. Actor type 
1. Politician 
2. Medical professional 
3. Interest group 




b. If the actor is an interest group, which type of interest group? 
1. Infertility  
2. General health 
3. Professional organization (ex. Society of Obstetrics and 
Gynecologists of Canada) 
4. Women’s Rights 
 
c. Name of actor/organization: __________________________________ 
 




e. If the author is NOT quoted with spoken voice, who references the 
actor? 
1. Politician 
2. Medical professional 
3. Interest group 
4. Members of the general public 
5. Academic 
6. Celebrity 
7. Writer of the article 
 
f. Does actor #_ support public funding of in vitro fertilization? 
1. Yes 
2. No  
3. Unclear/Neutral 




g. If YES to #3b, how does the actor frame their support for IVF funding? 
(primary) 
1. Cost-Effectiveness 
2. Infertility is a disease 
3. IVF is a medical need 
4. Infertility is a public health concern 
5. IVF is a human right 
6. Health inequalities are inequitable 
7. IVF will increase the country’s total fertility rate 
 
h. If YES to #3b, how does the actor frame their support for IVF funding? 
(secondary) 
1. Cost-Effectiveness 
2. Infertility is a disease 
3. IVF is a medical need 
4. Infertility is a public health concern 
5. IVF is a human right 
6. Health inequalities are inequitable 
7. IVF will increase the country’s total fertility rate 
LEAVE BLANK IF NONE STATED 
 
i. If the debate does not focus directly on IVF, how does the actor frame 
their support for the legislation?   
1. Cost-Effectiveness 
2. Will not cut medically necessary services 
LEAVE BLANK IF NONE STATED 
 
j. In general, who does the speaker cite as the primary “winners” or 
“losers” from public funding of IVF? (primary) 
1. General public 
2. Disease patients 
3. Medical professionals 
4. Government 
5. Interest groups 
 
k. In general, who does the speaker cite as the primary “winners or losers” 
from public funding of IVF? (secondary) 
1. General public 
2. Disease patients 
3. Medical professionals 
4. Government 
5. Interest groups 





l. If NO to #3b, how does the actor frame their opposition to IVF 
funding? (primary) 
1. Cost-Effectiveness 
2. Infertility is not a disease 
3. IVF is not a medical need 
4. Publicly-funded IVF may lead to other public health 
concerns 
5. IVF is not a human right 
6. Infertility is not inequitable 
7. IVF is experimental 
8. Public funding of IVF threatens the rights of women 
 
m. If NO to #3b, how does the actor frame their opposition to IVF 
funding? (secondary) 
1. Cost-Effectiveness 
2. Infertility is not a disease 
3. IVF is not a medical need 
4. Publicly-funded IVF may lead to other public health 
concerns 
5. IVF is not a human right 
6. Infertility is not inequitable 
7. IVF is experimental 
8. Public funding of IVF threatens the rights of women 
LEAVE BLANK IF NONE STATED 
 
n. If the debate does not focus directly on IVF, how does the actor frame 
their opposition to the legislation?   
1. Cost-Effectiveness 
2. Too much government power to define medical 
necessity 
3. Physicians will cut services if government does not pay 
LEAVE BLANK IF NONE STATED 
 
a. In general, who does the speaker cite as the primary “winners” or 
“losers” from the prevention of IVF funding? (primary) 
1. General public 
2. Disease patients 
3. Medical professionals 
4. Government 





b. In general, who does the speaker cite as the primary “winners or losers” 
from the prevention of IVF funding? (secondary) 
1. General public 
2. Disease patients 
3. Medical professionals 
4. Government 
5. Interest groups 
LEAVE BLANK IF NONE STATED 
 






















Politician 0 0 0 0 0 0 
Medical Professional 0 0 1 0 1 0 
Interest Group 0 4 2 0 0 0 
General Health 0 0 0 0 0 0 
Infertility Awareness 0 1 2 0 0 0 
Professional Organization 0 3 0 0 0 0 
Women's Rights 0 0 0 0 0 0 
Academic 0 0 1 0 0 0 
Celebrity 0 0 0 0 0 0 
Member of the General 






















Politician 4 3 1 0 2 0 
Medical Professional 1 4 4 0 1 0 
Interest Group 0 0 0 0 0 0 
General Health 0 0 0 0 0 0 
Infertility Awareness 1 3 3 0 1 0 
Professional Organization 0 4 0 0 0 0 
Women's Rights 0 0 0 0 0 0 
Academic 0 1 2 0 1 0 
Celebrity 0 0 6 0 1 0 
Member of the General 






















Politician 5 6 0 0 0  0  
Medical Professional 1 0 0 0 0 0 
Interest Group 0 0 0 0  0 5 
General Health 0  0  0  0  0  1 
Infertility Awareness 0  0  0  0  0   0 
Professional Organization 0  0  0  0  0   0 
Women's Rights 0  0  0  0  0  4 
Academic 0 0 0 1 0 0 
Celebrity 0 0 0 0 0 0  
Member of the General 






















Politician 0 2 0 1 0 0 
Medical Professional 0 0 0 0 0 0 
Interest Group 0 0 0 0 0 0 
General Health 0 0 0 0 0 0 
Infertility Awareness 0 0 0 0 0 0 
Professional Organization 0 0 0 0 0 0 
Women's Rights 0 0 0 0 0 0 
Academic 1 1 0 1 0 1 
Celebrity 0 0 0 0 0 0 
Member of the General 
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